La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Yves Agid And NotArgentine

List of bibliographic references

Number of relevant bibliographic references: 379.
Ident.Authors (with country if any)Title
000B09 Marie-Laure Welter [France] ; Michael Schüpbach [France, Suisse] ; Virginie Czernecki [France] ; Carine Karachi [France] ; Sara Fernandez-Vidal [France] ; Jean-Louis Golmard [France] ; Giulia Serra [France] ; Soledad Navarro [France] ; Arlette Welaratne [France] ; Andréas Hartmann [France] ; Valérie Mesnage [France] ; Fanny Pineau [France] ; Philippe Cornu [France] ; Bernard Pidoux [France] ; Yulia Worbe [France] ; Panayiotis Zikos [France, Grèce] ; David Grabli [France] ; Damien Galanaud [France] ; Anne-Marie Bonnet [France] ; Hayat Belaid [France] ; Didier Dormont [France] ; Marie Vidailhet [France] ; Luc Mallet [France] ; Jean-Luc Houeto [France] ; Eric Bardinet [France] ; Jerome Yelnik [France] ; Yves Agid [France]Optimal target localization for subthalamic stimulation in patients with Parkinson disease
000C80 W M M. Schuepbach [France] ; J. Rau ; K. Knudsen ; J. Volkmann ; P. Krack ; L. Timmermann ; T D H Lbig ; H. Hesekamp ; S M Navarro ; N. Meier ; D. Falk ; M. Mehdorn ; S. Paschen ; M. Maarouf ; M T Barbe ; G R Fink ; A. Kupsch ; D. Gruber ; G-H Schneider ; E. Seigneuret ; A. Kistner ; P. Chaynes ; F. Ory-Magne ; C. Brefel Courbon ; J. Vesper ; A. Schnitzler ; L. Wojtecki ; J-L Houeto ; B. Bataille ; D. Maltête ; P. Damier ; S. Raoul ; F. Sixel-Doering ; D. Hellwig ; A. Gharabaghi ; R. Krüger ; M O Pinsker ; F. Amtage ; J-M Régis ; T. Witjas ; S. Thobois ; P. Mertens ; M. Kloss ; A. Hartmann ; W H Oertel ; B. Post ; H. Speelman ; Yves Agid [France] ; C. Schade-Brittinger ; G. DeuschlNeurostimulation for Parkinson's disease with early motor complications.
000D09 Adèle Demain [France] ; G. W. Max Westby [France] ; Sara Fernandez-Vidal [France] ; Carine Karachi [France] ; Fabrice Bonneville [France] ; Manh Cuong Do [France] ; Christine Delmaire [France] ; Didier Dormont [France] ; Eric Bardinet [France] ; Yves Agid [France] ; Nathalie Chastan [France] ; Marie-Laure Welter [France]High-level gait and balance disorders in the elderly: a midbrain disease?
000D94 Stephan Klebe [France, Allemagne] ; Jean-Louis Golmard [France] ; Michael A. Nalls [États-Unis] ; Mohamad Saad [France] ; Andrew B. Singleton [États-Unis] ; Jose M. Bras [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Javier Simon-Sanchez [États-Unis, Pays-Bas] ; Peter Heutink [Pays-Bas] ; Gregor Kuhlenb Umer [Allemagne] ; Rim Charfi [France, Tunisie] ; Christine Klein [Allemagne] ; Johann Hagenah [Allemagne] ; Thomas Gasser [Allemagne] ; Isabel Wurster [Allemagne] ; Suzanne Lesage [France] ; Delia Lorenz [Allemagne] ; Günther Deuschl [Allemagne] ; Franck Durif [France] ; Pierre Pollak [France] ; Philippe Damier [France] ; François Tison [France] ; Alexandra Durr [France] ; Philippe Amouyel [France] ; Jean-Charles Lambert [France] ; Christophe Tzourio [France] ; Cécilia Maubaret [France] ; Fanny Charbonnier-Beaupel [France] ; Khadija Tahiri [France] ; Marie Vidailhet [France] ; Maria Martinez [France] ; Alexis Brice [France] ; Jean-Christophe Corvol [France] ; Yves Agid [France] ; M. Anheim ; A-M Bonnet ; M. Borg ; A. Brice ; E. Broussolle ; J-C Corvol ; Ph. Damier ; A. Destée ; A. Durr ; F. Durif ; S. Klebe ; E. Lohmann ; M. Martinez ; C. Penet ; P. Pollak ; P. Krack ; O. Rascol ; F. Tison ; C. Tranchant ; M. Vérin ; F. Viallet ; Vincent Plagnol ; Jose M. Bras ; Dena G. Hernandez ; Manu Sharma ; Una-Marie Sheerin ; Mohamad Saad ; Javier Sim N-Sánchez ; Claudia Schulte ; Suzanne Lesage ; Sigurlaug Sveinbjörnsd Ttir ; Philippe Amouyel ; Sampath Arepalli ; Gavin Band ; Roger A. Barker ; Céline Bellinguez ; Yoav Ben-Shlomo ; Henk W. Berendse ; Daniela Berg ; Kailash Bhatia ; Rob Ma De Bie ; Alessandro Biffi ; Bas Bloem ; Zoltan Bochdanovits ; Michael Bonin ; Kathrin Brockmann ; Janet Brooks ; David J. Burn ; Gavin Charlesworth ; Honglei Chen ; Patrick F. Chinnery ; Sean Chong ; Carl E. Clarke ; Mark R. Cookson ; J Mark Cooper ; Jean Christophe Corvol ; Carl Counsell ; Philippe Damier ; Jean-François Dartigues ; Panos Deloukas ; David T. Dexter ; Karin D. Van Dijk ; Allissa Dillman ; Frank Durif ; Sarah Edkins ; Jonathan R. Evans ; Thomas Foltynie ; Colin Freeman ; Jianjun Gao ; Michelle Gardner ; Raphael Gibbs ; Alison Goate ; Emma Gray ; Rita Guerreiro ; Mar Gústafsson ; Clare Harris ; Garrett Hellenthal ; Jacobus J. Van Hilten ; Albert Hofman ; Albert Hollenbeck ; Janice Holton ; Michele Hu ; Xuemei Huang ; Heiko Huber ; Gavin Hudson ; Sarah E. Hunt ; Johanna Huttenlocher ; Thomas Illig ; Pálmi V. J Nsson ; Cordelia Langford ; Andrew Lees ; Peter Lichtner ; Patricia Limousin ; Grisel Lopez ; Delia Lorenz ; Alisdair Mcneill ; Catriona Moorby ; Huw Morris ; Karen E. Morrison ; Ese Mudanohwo ; Sean S. O'Sullivan ; Justin Pearson ; Richard Pearson ; Joel S. Perlmutter ; Hjörvar Pétursson ; Matti Pirinen ; Pierre Pollak ; Bart Post ; Simon Potter ; Bernard Ravina ; Tamas Revesz ; Olaf Riess ; Fernando Rivadeneira ; Patrizia Rizzu ; Mina Ryten ; Stephen Sawcer ; Anthony Schapira ; Hans Scheffer ; Karen Shaw ; Ira Shoulson ; Ellen Sidransky ; Rohan De Silva ; Colin Smith ; Chris Ca Spencer ; Hreinn Stefánsson ; Stacy Steinberg ; Joanna D. Stockton ; Amy Strange ; Zhan Su ; Kevin Talbot ; Carlie M. Tanner ; Avazeh Tashakkori-Ghanbaria ; François Tison ; Daniah Trabzuni ; Bryan J. Traynor ; G. Uitterlinden ; Jana Vandrovcova ; Daan Velseboer ; Marie Vidailhet ; Damjan Vukcevic ; Robert Walker ; Bart Van De Warrenburg ; Michael E. Weale ; Mirdhu Wickremaratchi ; Nigel Williams ; Caroline H. Williams-Gray ; Sophie Winder-Rhodes ; Maria Martinez ; Peter Donnelly ; John Hardy ; Peter Heutink ; Alexis Brice ; Thomas Gasser ; Nicholas W. Wood ; Andrew B. SingletonThe Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
000E26 Yves Agid [France]Subconscious man: The basal ganglia as a target for intervention in emotional disorders
001152 Yohann Brun [France] ; Carine Karachi ; Sara Fernandez-Vidal ; Nicolas Jodoin ; David Grabli ; Eric Bardinet ; Luc Mallet ; Yves Agid [France] ; Jerome Yelnik ; Marie-Laure WelterDoes unilateral basal ganglia activity functionally influence the contralateral side? What we can learn from STN stimulation in patients with Parkinson's disease.
001534 Paul Mccrone [Royaume-Uni] ; Christine Anne Mary Payan [France] ; Martin Knapp [Royaume-Uni] ; Albert Ludolph [Allemagne] ; Yves Agid [France] ; P. Nigel Leigh [Royaume-Uni] ; Gilbert Bensimon [France]The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom
001594 Christine A. M. Payan [France] ; François Viallet [France] ; Bernhard G. Landwehrmeyer [Allemagne] ; Anne-Marie Bonnet [France] ; Michel Borg [France] ; Franck Durif [France] ; Lucette Lacomblez [France] ; Frédéric Bloch [France] ; Marc Verny [France] ; Jacques Fermanian [France] ; Yves Agid [France] ; Albert C. Ludolph [Allemagne] ; Peter N. Leigh [Royaume-Uni] ; Gilbert Bensimon [France]Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE
001648 Jean-Christophe Corvol [France] ; Cécilia Bonnet [France] ; Fanny Charbonnier-Beaupel [France] ; Anne-Marie Bonnet [France] ; Marie-Hélène Fiévet [France] ; Agnès Bellanger [France] ; Emmanuel Roze [France] ; Gayané Meliksetyan [France] ; Mouna Ben Djebara [France] ; Andreas Hartmann [France] ; Lucette Lacomblez [France] ; Cédric Vrignaud [France] ; Noël Zahr [France] ; Yves Agid [France] ; Jean Costentin [France] ; Jean-Sébastien Hulot [France] ; Marie Vidailhet [France]The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial
001989 W M M. Schüpbach [France] ; J-C Corvol ; V. Czernecki ; M B Djebara ; J-L Golmard ; Yves Agid [France] ; A. HartmannSegmental progression of early untreated Parkinson's disease: a novel approach to clinical rating.
001A93 Suzanne Lesage ; Etienne Patin ; Christel Condroyer ; Anne-Louise Leutenegger ; Ebba Lohmann ; Nir Giladi ; Anat Bar-Shira ; Soraya Belarbi ; Nassima Hecham ; Pierre Pollak ; Anne-Marie Ouvrard-Hernandez ; Soraya Bardien ; Jonathan Carr ; Traki Benhassine ; Hiroyuki Tomiyama ; Caroline Pirkevi ; Tarik Hamadouche [Algérie] ; Ccile Cazeneuve [France] ; A. Nazli Basak ; Nobutaka Hattori ; Alexandra Drr [France] ; Meriem Tazir ; Avi Orr-Urtreger ; Lluis Quintana-Murci ; Alexis Brice [France] ; Yves Agid [France] ; A.-M. Bonnet ; M. Borg ; A. Brice ; E. Broussolle ; Ph. Damier ; A. Deste ; A. Drr ; F. Durif ; E. Lohmann ; M. Martinez ; C. Penet ; P. Pollak ; O. Rascol ; F. Tison ; C. Tranchant ; A. Troiano ; M. Vrin ; F. Viallet ; M. VidailhetParkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans
001B08 Richard G. Brown [Royaume-Uni] ; Lucette Lacomblez [France] ; Bernard G. Landwehrmeyer [Allemagne] ; Thomas Bak [Royaume-Uni] ; Ingo Uttner [Allemagne] ; Bruno Dubois [France] ; Yves Agid [France] ; Albert Ludolph [Allemagne] ; Gilbert Bensimon [France] ; Christine Payan [France] ; Nigel P. Leigh [Royaume-Uni]Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy
001B60 Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France]Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study
001B73 Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim L. Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada]Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease
001B93 Peter Redgrave [Royaume-Uni] ; Manuel Rodriguez [Espagne] ; Yoland Smith [États-Unis] ; Maria C. Rodriguez-Oroz [Espagne] ; Stephane Lehericy [France] ; Hagai Bergman [Israël] ; Yves Agid [France] ; Mahlon R. Delong [États-Unis] ; Jose A. Obeso [Espagne]Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease
001D16 W. M. M. Schüpbach [France, Suisse] ; J.-C. Corvol [France] ; V. Czernecki [France] ; M. B. Djebara [France] ; J.-L. Golmard [France] ; Yves Agid [France] ; A. Hartmann [France]Segmental progression of early untreated Parkinson's disease: a novel approach to clinical rating
001E70 H. El Otmani [France] ; N. Jodoin ; S. Yaici ; M-L Welter ; A-M Bonnet ; S. Navarro ; B. Pidoux ; D. Dormont ; P. Cornu ; Yves Agid [France][Can subthalamic nucleus stimulation reveal parkinsonian rest tremor?].
001F58 Pablo Ibá Ez [France] ; Suzanne Lesage ; Sabine Janin ; Ebba Lohmann ; Frank Durif ; Alain Destée [France] ; Anne-Marie Bonnet ; Christine Brefel-Courbon ; Simon Heath ; Diana Zelenika ; Yves Agid [France] ; Alexandra Dürr ; Alexis BriceAlpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms.
001F62 Maria-João Ribeiro [France] ; Stéphane Thobois ; Ebba Lohmann ; Sophie Tezenas Du Montcel ; Suzanne Lesage ; Antoine Pelissolo ; Bruno Dubois ; Luc Mallet ; Pierre Pollak ; Yves Agid [France] ; Emmanuel Broussolle ; Alexis Brice ; Philippe RemyA multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.
001F64 Ebba Lohmann [France] ; Laurence Leclere ; Francesca De Anna ; Suzanne Lesage ; Bruno Dubois ; Yves Agid [France] ; Alexandra Dürr ; Alexis BriceA clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations.
001F91 N. Chastan [France] ; G. W. M. Westby [France] ; J. Yelnik [France] ; E. Bardinet [France] ; M. C. Do [France] ; Yves Agid [France] ; M. L. Welter [France]Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease
002045 A. H. Schapira [Royaume-Uni] ; Yves Agid [France] ; P. Barone [Italie] ; P. Jenner [Royaume-Uni] ; M. R. Lemke [Allemagne] ; Werner Poewe [Autriche] ; O. Rascol [France] ; H. Reichmann [Allemagne] ; E. Tolosa [Espagne]Perspectives on recent advances in the understanding and treatment of Parkinson’s disease
002047 Sophie Lavault [France] ; Frederic Bloch [France] ; Jean-Luc Houeto [France] ; Eric Konofal [France] ; Marie-Laure Welter [France] ; Yves Agid [France] ; Isabelle Arnulf [France]Periodic leg movements and REM sleep without atonia in Parkinson's disease with camptocormia
002062 Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Jaime Kulisevsky [Espagne] ; Aana-Lena Tornqvist [Suède] ; Jean-Luc Houeto [France] ; Bernard Pidoux [France] ; Anne-Marie Bonnet [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Nadege Van Blercom [France] ; Jing Xie [France] ; José Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Jurge Guridi [Espagne] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Alexandre A. Gironell [Espagne] ; Juan Molet [Espagne] ; Benta Pascual-Sedano [Espagne] ; Stig Rehncrona [Suède] ; Elena Moro [Canada] ; Anthony C. Lang [Canada] ; Andres M. Lozano [Canada] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Maria Fiorella Contarino [Pays-Bas] ; Luigi Romito [Italie] ; Marc Janssens [Pays-Bas] ; Yves Agid [France]Long‐term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease
002075 Nathalie Chastan [France] ; Manh Cuong Do [France] ; Fabrice Bonneville [France] ; Frédéric Torny [France] ; Frédéric Bloch [France] ; G. W. Max Westby [France] ; Didier Dormont [France] ; Yves Agid [France] ; Marie-Laure Welter [France]Gait and balance disorders in Parkinson's disease: Impaired active braking of the fall of centre of gravity
002133 H. El Otmani [France] ; N. Jodoin [France] ; S. Yaici [France] ; M.-L. Welter [France] ; A.-M. Bonnet [France] ; S. Navarro [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France]La stimulation du noyau subthalamique peut-elle révéler un tremblement de repos parkinsonien ?
002155 Pablo Ibanez [France, Royaume-Uni] ; LESAGE [France] ; Sabine Janin [France] ; Ebba Lohmann [France] ; Frank Durif [France] ; Alain Destée [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Simon Heath [France] ; Diana Zelenika [France] ; Yves Agid [France] ; Alexandra Dürr [France] ; Alexis Brice [France]α-Synuclein Gene Rearrangements in Dominantly Inherited Parkinsonism : Frequency, Phenotype, and Mechanisms
002164 Gilbert Bensimon [France] ; Albert Ludolph [Allemagne] ; Yves Agid [France] ; Marie Vidailhet [France] ; Christine Payan [France] ; P. Nigel Leigh [Royaume-Uni]Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders : The NNIPPS Study
002196 Pierre Payoux [France] ; Philippe Remy [France] ; Malika Miloudi [France] ; Jean-Luc Houeto [France] ; Claudio Stadler [France] ; Boulos-Paul Bejjani [France] ; Jérome Yelnik [France] ; Yves Samson [France] ; Olivier Rascol [France] ; Yves Agid [France] ; Philippe Damier [France]Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease
002211 Eric Bardinet [France] ; Manik Bhattacharjee [France] ; Didier Dormont [France] ; Bernard Pidoux [France] ; Grégoire Malandain [France] ; Michael Schüpbach [France] ; Nicholas Ayache [France] ; Philippe Cornu [France] ; Yves Agid [France] ; Jérome Yelnik [France]A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease : Clinical article
002214 E. Lohmann [France] ; S. Thobois [France] ; S. Lesage [France] ; E. Broussolle [France] ; S. Tezenas Du Montcel [France] ; M.-J. Ribeiro [France] ; P. Remy [France] ; A. Pelissolo [France] ; B. Dubois [France] ; L. Mallet [France] ; P. Pollak [France] ; Yves Agid [France] ; A. Brice [France]A multidisciplinary study of patients with early-onset PD with and without parkin mutations
002286 Gilbert Bensimon [France] ; Albert Ludolph [Allemagne] ; Yves Agid [France] ; Marie Vidailhet [France] ; Christine Payan [France] ; P. Nigel Leigh [Royaume-Uni]Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study
002291 W M Michael Schüpbach [France] ; Yves Agid [France]Psychosocial adjustment after deep brain stimulation in Parkinson's disease.
002325 Fabrice Bonneville [France] ; Frédéric Bloch ; Ewa Kurys ; Sophie Tezenas Du Montcel ; Marie-Laure Welter ; Anne-Marie Bonnet ; Yves Agid [France] ; Didier Dormont ; Jean-Luc HouetoCamptocormia and Parkinson's disease: MR imaging.
002426 Ebba Lohmann [France] ; Marie-Laure Welter [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Suzanne Lesage [France] ; Sophie Laine [France] ; Marie-Laure Tanguy [France] ; Jean-Luc Houeto [France] ; Valérie Mesnage [France] ; Pierre Pollak [France] ; Pierre Alexandra Durr [France] ; Yves Agid [France] ; Alexis Brice [France]Are parkin patients particularly suited for deep‐brain stimulation?
002428 Virginie Czernecki [France] ; Michael Schüpbach [France, Suisse] ; Sadek Yaici [France] ; Richard Lévy [France] ; Eric Bardinet [France] ; Jérôme Yelnik [France] ; Bruno Dubois [France] ; Yves Agid [France]Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom
002601 D. Maltête [France] ; N. Jodoin ; C. Karachi ; J L Houeto ; S. Navarro ; P. Cornu ; Yves Agid [France] ; M L WelterSubthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.
002602 Luc Mallet [France] ; Michael Schüpbach [France] ; Karim N'Diaye [France] ; Philippe Remy [France] ; Eric Bardinet [France] ; Virginie Czernecki [France] ; Marie-Laure Welter [France] ; Antoine Pelissolo ; Merle Ruberg [France] ; Yves Agid [France] ; Jérôme Yelnik [France]Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior
002610 W M M. Schüpbach [France] ; D. Maltête ; J L Houeto ; S Tezenas Du Montcel ; L. Mallet ; M L Welter ; M. Gargiulo ; C. Béhar ; A M Bonnet ; V. Czernecki ; B. Pidoux ; S. Navarro ; D. Dormont ; P. Cornu ; Yves Agid [France]Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial.
002676 Valérie Cochen De Cock [France] ; Marie Vidailhet [France] ; Smaranda Leu [France] ; Antonio Texeira [France] ; Emmanuelle Apartis [France] ; Alexis Elbaz [France] ; Emmanuel Roze [France] ; Jean Claude Willer [France] ; Jean Philippe Derenne [France] ; Yves Agid [France] ; Isabelle Arnulf [France]Restoration of normal motor control in Parkinson's disease during REM sleep
002690 Michael W. M. Schüpbach [France] ; Marie Laure Welter [France] ; Anne Marie Bonnet [France] ; Alexis Elbaz [France] ; Brandon R. Grossardt [États-Unis] ; Valerie Mesnage [France] ; Jean Luc Houeto [France] ; David Maltête [France] ; Luc Mallet [France] ; Walter A. Rocca [États-Unis] ; Alain Mallet [France] ; Yves Agid [France]Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus
002792 Michael Schüpbach [France] ; Ebba Lohmann [France] ; Mathieu Anheim [France] ; Suzanne Lesage [France] ; Virginie Czernecki [France] ; Sadek Yaici [France] ; Yulia Worbe [France] ; Perrine Charles [France] ; Marie-Laure Welter [France] ; Pierre Pollak [France] ; Alexandra Dürr [France] ; Yves Agid [France] ; Alexis Brice [France]Subthalamic nucleus stimulation is efficacious in patients with parkinsonism and LRRK2 mutations
002799 Valérie Cochen De Cock [France] ; Marie Vidailhet [France] ; Smaranda Leu [France] ; Antonio Texeira [France] ; Emmanuelle Apartis [France] ; Alexis Elbaz [France] ; Emmanuel Roze [France] ; Jean Claude Willer [France] ; Jean Philippe Derenne [France] ; Yves Agid [France] ; Isabelle Arnulf [France]Restoration of normal motor control in Parkinson's disease during REM sleep
002808 W. M. M. Schüpbach [France] ; D. Maltete [France] ; J. L. Houeto [France] ; S. Tezenas Du Montcel [France] ; L. Mallet [France] ; M. L. Welter [France] ; M. Gargiulo [France] ; C. Behar [France] ; A. M. Bonnet [France] ; V. Czernecki [France] ; B. Pidoux [France] ; S. Navarro [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France]Neurosurgery at an earlier stage of Parkinson disease : A randomized, controlled trial
002818 Suzanne Lesage [France] ; Sabine Janin [France] ; Ebba Lohmann [France] ; Anne-Louise Leutenegger [France] ; Laurence Leclere [France] ; Francois Viallet [France] ; Pierre Pollak [France] ; Franck Durif [France] ; Stephane Thobois [France] ; Valérie Layet [France] ; Marie Vidailhet [France] ; Yves Agid [France] ; Alexandra Dürr [France] ; Alexis Brice [France]LRRK2 exon 41 mutations in sporadic parkinson disease in europeans
002824 Jean-Christophe Corvol [France] ; Jean-Baptiste Anzouan-Kacou [France] ; Elodie Fauveau [France] ; Anne-Marie Bonnet [France] ; Bénédicte Lebrun-Vignes [France] ; Camille Girault [France] ; Yves Agid [France] ; Philippe Lechat [France] ; Richard Isnard [France] ; Lucette Lacomblez [France]Heart Valve Regurgitation, Pergolide Use, and Parkinson Disease : An Observational Study and Meta-analysis
002903 Yves Agid [France] ; M. Schüpbach ; M. Gargiulo ; L. Mallet ; J L Houeto ; C. Behar ; D. Maltête ; V. Mesnage ; M L WelterNeurosurgery in Parkinson's disease: the doctor is happy, the patient less so?
002904 M. Schüpbach [France] ; M. Gargiulo ; M L Welter ; L. Mallet ; C. Béhar ; J L Houeto ; D. Maltête ; V. Mesnage ; Yves Agid [France]Neurosurgery in Parkinson disease: a distressed mind in a repaired body?
002930 Fabien Etchepare [France] ; Sylvie Rozenberg ; Tristan Mirault ; Anne-Marie Bonnet ; Colette Lecorre ; Yves Agid [France] ; Pierre Bourgeois ; Bruno FautrelBack problems in Parkinson's disease: an underestimated problem.
002973 Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommée [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France]Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
002974 F. Bloch [France] ; J L Houeto ; S. Tezenas Du Montcel ; F. Bonneville [France] ; F. Etchepare ; M L Welter [France] ; S. Rivaud-Pechoux [France] ; V. Hahn-Barma [France] ; T. Maisonobe ; C. Behar [France] ; J Y Lazennec ; E. Kurys [France] ; I. Arnulf [France] ; A M Bonnet [France] ; Yves Agid [France]Parkinson’s disease with camptocormia
002978 Pablo Iba N Ez ; Suzanne Lesage ; Ebba Lohmann ; Ste Phane Thobois ; Giuseppe De Michele [Italie] ; Michel Borg [France] ; Yves Agid [France] ; Alexandra Du Rr ; Alexis BriceMutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa
002A77 Fabien Etchepare [France] ; Sylvie Rozenberg [France] ; Tristan Mirault [France] ; Anne-Marie Bonnet [France] ; Colette Lecorre [France] ; Yves Agid [France] ; Pierre Bourgeois [France] ; Bruno Fautrel [France]Douleurs rachidiennes au cours de la maladie de Parkinson : un problème sous-estimé
002A90 Jean-Luc Houeto [France] ; Luc Mallet [France] ; Valérie Mesnage [France] ; Sophie Tezenas Du Montcel [France] ; Cécile Behar [France] ; Marcela Gargiulo [France] ; Frederic Tomy [France] ; Antoine Pelissolo [France] ; Marie-Laure Welter [France] ; Yves Agid [France]Subthalamic stimulation in parkinson disease : Behavior and social adaptation
002B01 R. Djaldetti [Israël] ; E. Melamed [Israël] ; F. Bloch [France] ; J. L. Houeto [France] ; S. Tezenas Du Montcel [France] ; F. Bonneville [France] ; F. Etchepare [France] ; M. L. Welter [France] ; S. Rivaud-Pechoux [France] ; V. Hahn-Barma [France] ; T. Maisonobe [France] ; C. Behar [France] ; J. Y. Lazennec [France] ; E. Kurys [France] ; I. Arnulf [France] ; A. M. Bonnet [France] ; Yves Agid [France]Parkinson's disease with camptocormia. Commentary
002B06 M. Schüpbach [France] ; M. Gargiulo [France] ; M. L. Welter [France] ; L. Mallet [France] ; C. Behar [France] ; J. L. Houeto [France] ; D. Maltete [France] ; V. Mesnage [France] ; Yves Agid [France]Neurosurgery in Parkinson disease : A distressed mind in a repaired body?
002B10 Pablo Ibanez [France] ; Suzanne Lesage [France] ; Ebba Lohmann [France] ; Stéphane Thobois [France] ; Giuseppe De Michele [Italie] ; Michel Borg [France] ; Yves Agid [France] ; Alexandra Dürr [France] ; Alexis Brice [France]Mutational analysis of the PINK I gene in early-onset parkinsonism in Europe and North Africa
002B68 Eric Bardinet [France] ; Didier Dormont ; Grégoire Malandain ; Manik Bhattacharjee ; Bernard Pidoux ; Christian Saleh ; Philippe Cornu ; Nicholas Ayache ; Yves Agid [France] ; Jérôme YelnikRetrospective cross-evaluation of an histological and deformable 3D atlas of the basal ganglia on series of Parkinsonian patients treated by deep brain stimulation.
002B73 F. Bonneville [France] ; M L Welter ; C. Elie ; S Tezenas Du Montcel ; D. Hasboun ; C. Menuel ; J L Houeto ; A M Bonnet ; V. Mesnage ; B. Pidoux ; S. Navarro ; P. Cornu ; Yves Agid [France] ; D. DormontParkinson disease, brain volumes, and subthalamic nucleus stimulation.
002B88 Mathias Pessiglione [France] ; Virginie Czernecki ; Bernard Pillon ; Bruno Dubois ; Michael Schüpbach ; Yves Agid [France] ; Léon TremblayAn effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution.
002C17 W M M. Schüpbach [France] ; N. Chastan [France] ; M L Welter [France] ; J L Houeto [France] ; V. Mesnage [France] ; A M Bonnet [France] ; V. Czernecki [France] ; D. Maltête [France] ; A. Hartmann [France] ; L. Mallet [France] ; B. Pidoux [France] ; D. Dormont [France] ; S. Navarro [France] ; P. Cornu [France] ; A. Mallet [France] ; Yves Agid [France]Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up
002C22 Eric Bardinet [France] ; Didier Dormont [France] ; Grégoire Malandain [France] ; Manik Bhattacharjee [France] ; Bernard Pidoux [France] ; Christian Saleh [France] ; Philippe Cornu [France] ; Nicholas Ayache [France] ; Yves Agid [France] ; Jérôme Yelnik [France]Retrospective Cross-Evaluation of an Histological and Deformable 3D Atlas of the Basal Ganglia on Series of Parkinsonian Patients Treated by Deep Brain Stimulation
002C73 V. Czernecki [France] ; B. Pillon [France] ; J L Houeto [France] ; M L Welter [France] ; V. Mesnage [France] ; Yves Agid [France] ; B. Dubois [France]Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson’s disease?
002C84 M. C. Rodriguez-Oroz ; J. A. Obeso ; A. E. Lang ; J.-L. Houeto ; P. Pollak ; S. Rehncrona ; J. Kulisevsky ; A. Albanese ; J. Volkmann ; M. I. Hariz ; N. P. Quinn ; J. D. Speelman [Pays-Bas] ; J. Guridi ; I. Zamarbide ; A. Gironell ; J. Molet ; B. Pascual-Sedano ; B. Pidoux ; A. M. Bonnet ; Yves Agid [France] ; J. Xie ; A.-L. Benabid ; A. M. Lozano ; J. Saint-Cyr ; L. Romito ; M. F. Contarino [Italie] ; M. Scerrati ; V. Fraix ; N. Van BlercomBilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up
002C89 Morgane Caer [France] ; Karine Viala [France] ; Richard Levy [France] ; Thierry Maisonobe [France] ; Florence Chochon [France] ; Agnès Lombès [France] ; Yves Agid [France]Adult‐onset chorea and mitochondrial cytopathy
002D07 M. Gargiulo [France] ; M. Schupbach [France] ; C. Behar [France] ; M. L. Welter [France] ; D. Maltete [France] ; J.-L Houeto [France] ; L. Mallet [France] ; V. Mesnage [France] ; B. Pillon [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; S. Navarro [France] ; Yves Agid [France]Neurochirurgie de la maladie de Parkinson: conséquences psychologiques et familiales
002D46 Isabelle Arnulf [France] ; Milagros Merino-Andreu [France] ; Frédéric Bloch [France] ; Eric Konofal [France] ; Marie Vidailhet [France] ; Valérie Cochen [France] ; Jean-Philippe Derenne [France] ; Yves Agid [France]REM Sleep behavior disorder and REM Sleep without atonia in patients with progressive supranuclear palsy
002D54 F. Bonneville [France] ; M. L. Welter [France] ; C. Elie [France] ; S. Tezenas Du Montcel [France] ; D. Hasboun [France] ; C. Menuel [France] ; J. L. Houeto [France] ; A. M. Bonnet [France] ; V. Mesnage [France] ; B. Pidoux [France] ; S. Navarro [France] ; P. Cornu [France] ; Yves Agid [France] ; D. Dormont [France]Parkinson disease, brain volumes, and subthalamic nucleus stimulation
002D69 Suzanne Lesage [France] ; Pablo Ibanez [France] ; Ebba Lohmann [France] ; Pierre Pollak [France] ; Francois Tison [France] ; Myriem Tazir [Algérie] ; Anne-Louise Leutenegger [France] ; Joao Guimaraes [Portugal] ; Anne-Marie Bonnet [France] ; Yves Agid [France] ; Alexandra Durr [France] ; Alexis Brice [France]G2019S LRRK2 mutation in French and North African families with Parkinson's disease
002D79 M. Samuel [Royaume-Uni] ; V. Voon [États-Unis] ; V. Czernecki [France] ; B. Pillon [France] ; J. L. Houeto [France] ; M. L. Welter [France] ; V. Mesnage [France] ; Yves Agid [France] ; B. Dubois [France]Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?. Commentary
002D92 Hans-Joachim Freund [Allemagne] ; M. C. Rodriguez-Oroz [Espagne] ; J. A. Obeso [Espagne] ; A. E. Lang [Canada] ; J.-L. Houeto [France] ; P. Pollak [France] ; S. Rehncrona [France] ; J. Kulisevsky [Espagne] ; A. Albanese [Italie] ; J. Volkmann [Allemagne] ; M. I. Hariz [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; J. D. Speelman [Pays-Bas] ; J. Guridi [Espagne] ; I. Zamarbide [Espagne] ; A. Gironell [Espagne] ; J. Molet [Espagne] ; B. Pascual-Sedano [Espagne] ; B. Pidoux [France] ; A. M. Bonnet [France] ; Yves Agid [France] ; J. Xie [France] ; A.-L. Benabid [France] ; A. M. Lozano [Canada] ; J. Saint-Cyr [Canada] ; L. Romito [Italie] ; M. F. Contarino [Italie] ; M. Scerrati [Italie] ; V. Fraix [France] ; N. Van Blercom [France]Bilateral deep brain stimulation in Parkinson's disease : a multicentre study with 4 years follow-up. Commentary
002E53 P. Ibá Ez [France] ; E. Lohmann ; P. Pollak ; F. Durif ; C. Tranchant ; Yves Agid [France] ; A. Dürr ; A. BriceAbsence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease.
002F88 David Maltete [France] ; Soledad Navarro [France] ; Marie-Laure Welter [France] ; Sabine Roche [France] ; Anne-Marie Bonnet [France] ; Jean-Luc Houeto [France] ; Valérie Mesnage [France] ; Bernard Pidoux [France] ; Didier Dormont [France] ; Philippe Cornu [France] ; Yves Agid [France]Subthalamic stimulation in Parkinson disease: With or without anesthesia?
002F89 Pierre Payoux [France] ; Philippe Remy [France] ; Philipe Damier [France] ; Malika Miloudi [France] ; Isabelle Loubinoux [France] ; Bernard Pidoux [France] ; Véronique Gaura [France] ; Olivier Rascol [France] ; Yves Samson [France] ; Yves Agid [France]Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease
003008 Didier Dormont [France] ; Kenneth G. Ricciardi [France] ; Dominique Tande [France] ; Karine Parain [France] ; Carole Menuel [France] ; Damien Galanaud [France] ; Soledad Navarro [France] ; Philippe Cornu [France] ; Yves Agid [France] ; Jérome Yelnik [France]Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data
003019 Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Anne-Marie Bonnet [France] ; Paul-Boulos Bejjani [France] ; Valérie Mesnage [France] ; Didier Dormont [France] ; Soledad Navarro [France] ; Philippe Cornu [France] ; Yves Agid [France] ; Bernard Pidoux [France]Effects of high-frequency Stimulation on subthalamic neuronal activity in parkinsonian patients
003034 P. Ibanez [France] ; A-M Bonnet [France] ; B. Debarges [France] ; E. Lohmann [France] ; F. Tison [France] ; P. Pollak ; Yves Agid [France] ; A. Durr [France] ; A. Brice [France] ; Andrew Singleton [États-Unis] ; Katrina Gwinn-Hardy [États-Unis]Causal relation between α-synuclein gene duplication and familial Parkinson's. Commentary disease
003039 P. Ibanez [France] ; E. Lohmann [France] ; P. Pollak [France] ; F. Durif [France] ; C. Tranchant [France] ; Yves Agid [France] ; A. Dürr [France] ; A. Brice [France]Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease
003059 M. Merino-Andreu [France] ; I. Arnulf ; E. Konofal ; J P Derenne ; Yves Agid [France]Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness.
003123 Magali Periquet ; Morwena Latouche ; Ebba Lohmann ; Nina Rawal ; Giuseppe De Michele ; Sylvain Ricard ; He Lio Teive ; Vale Rie Fraix ; Marie Vidailhet ; David Nicholl ; Paolo Barone ; Nick W. Wood [Royaume-Uni] ; Salmo Raskin ; Jean-Franc Ois Deleuze ; Yves Agid [France] ; Alexandra Du Rr ; Alexis BriceParkin mutations are frequent in patients with isolated early‐onset parkinsonism
003129 Emmanuelle Waubant [France, États-Unis] ; Sophie Tezenas Du Montcel [France] ; Charles Jedynak [France] ; Michael Obadia [France] ; Hassan Hosseini [France] ; Philippe Damier [France] ; Catherine Lubetzki [France] ; Yves Agid [France] ; Jean-Denis Degos [France]Multiple sclerosis tremor and the Stewart‐Holmes manoeuvre
003136 Ebba Lohmann [France] ; Magali Periquet [France] ; Vincenzo Bonifati [Italie] ; Nick W. Wood [Royaume-Uni] ; Giuseppe De Michele [Italie] ; Anne-Marie Bonnet [France] ; Valérie Fraix [France] ; Emmanuel Broussolle [France] ; Martin W. I. M. Horstink [Pays-Bas] ; Marie Vidailhet [France] ; Patrice Verpillat [France] ; Thomas Gasser [Allemagne] ; David Nicholl [Royaume-Uni] ; Hélio Teive [Brésil] ; Salmo Raskin [Brésil] ; Olivier Rascol ; Alain Destée [France] ; Merle Ruberg [France] ; Francesca Gasparini [France] ; Giuseppe Meco [Italie] ; Yves Agid [France] ; Alexandra Durr [France] ; Alexis Brice [France]How much phenotypic variation can be attributed to parkin genotype?
003210 L. Mallet [France] ; V. Mesnage [France] ; J.-L. Houeto [France] ; A. Pelissolo [France] ; J. Yelnik [France] ; C. Behar [France] ; M. Gargiulo [France] ; M.-L. Welter [France] ; A.-M. Bonnet [France] ; B. Pillon [France] ; P. Cornu [France] ; D. Dormont [France] ; B. Pidoux [France] ; J.-F. Allilaire [France] ; Yves Agid [France]Compulsions, Parkinson et stimulation
003220 Stéphane Thobois [France] ; Maria-Joao Ribeiro [France] ; Ebba Lohmann [France] ; Alexandra Dürr [France] ; Pierre Pollak [France] ; Olivier Rascol [France] ; Stéphane Guillouet [France] ; Elizabeth Chapoy [France] ; Nicolas Costes [France] ; Yves Agid [France] ; Philippe Remy [France] ; Alexis Brice [France] ; Emmanuel Broussolle [France]Young-onset Parkinson disease with and without parkin gene mutations: A fluorodopa F 18 positron emission tomography study
003227 Jean-Luc Houeto [France] ; Marie-Laure Welter [France] ; Paul-Boulos Bejjani [Liban] ; Sophie Tezenas Du Montcel [France] ; Anne-Marie Bonnet [France] ; Valerie Mesnage [France] ; Soledad Navarro [France] ; Bernard Pidoux [France] ; Didier Dormont [France] ; Philippe Cornu [France] ; Yves Agid [France]Subthalamic stimulation in Parkinson disease: Intraoperative predictive factors
003237 Bechir Jarraya [France] ; Anne-Marie Bonnet [France] ; Charles Duyckaerts [France] ; Jean-Luc Houetc [France] ; Philippe Cornu [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France]Parkinson's disease, subthalamic stimulation, and selection of candidates: A pathologic study
003238 Yves Agid [France] ; I. Arnulf [France] ; P. Bejjani [États-Unis] ; F. Bloch [France] ; A. M. Bonnet [France] ; P. Damier [France] ; B. Dubois [France] ; C. Francois [France] ; J. L. Houeto [France] ; D. Iacono [France] ; C. Karachi [France] ; V. Mesnage [France] ; O. Messouak [France] ; M. Vidailhet [France] ; M. L. Welter [France] ; J. Yelnik [France]Parkinson's disease is a neuropsychiatric disorder
003243 Baptiste A. Faucheux [France] ; Marie-Elise Martin [France] ; Carole Beaumont [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease
003252 Jérome Yelnik [France] ; Philippe Damier ; Sophie Demeret ; David Gervais ; Eric Bardinet ; Boulos-Paul Bejjani ; Chantal Francois ; Jean-Luc Houeto ; Isabelle Arnulf ; Didier Dormont ; Damien Galanaud ; Bernard Pidoux ; Philippe Cornu ; Yves Agid [France]Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method
003256 Mathias Pessiglione [France] ; Dominique Guehl [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] ; Jean Feger [France] ; Léon Tremblay [France]Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson's disease
003272 Christoph-Burkhard Lücking [France] ; Véronique Chesneau [France] ; Ebba Lohmann [France] ; Patrice Verpillat [France] ; Cyprien Dulac [France] ; Anne-Marie Bonnet [France] ; Francesca Gasparini [France] ; Yves Agid [France] ; Alexandra Dürr [France] ; Alexis Brice [France]Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease
003355 V. Mesnage [France] ; J Houeto [France] ; M Welter [France] ; Yves Agid [France] ; B. Pidoux ; D. Dormont ; P. CornuParkinson's disease: neurosurgery at an earlier stage?
003388 B-P Bejjani [Liban] ; I. Arnulf [France] ; J-L Houeto [France] ; D. Milea [France] ; S. Demeret [France] ; B. Pidoux ; P. Damier [France] ; P. Cornu ; D. Dormont ; Yves Agid [France]Concurrent excitatory and inhibitory effects of high frequency stimulation: an oculomotor study
003393 J L Houeto [France] ; V. Mesnage [France] ; L. Mallet [France] ; B. Pillon [France] ; M. Gargiulo [France] ; S Tezenas Du Moncel [France] ; A M Bonnet [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France]Behavioural disorders, Parkinson's disease and subthalamic stimulation
003433 P.-P. Michel [France] ; E.-C. Hirsch [France] ; Yves Agid [France]Maladie de Parkinson : mécanismes de la mort cellulaire
003488 I. Arnulf [France] ; E. Konofal [France] ; M. Merino-Andreu [France] ; J. L. Houeto [France] ; V. Mesnage [France] ; M. L. Welter [France] ; L. Lacomblez [France] ; J. L. Golmard [France] ; J. P. Derenne [France] ; Yves Agid [France]Parkinson's disease and sleepiness: An integral part of PD
003504 Baptiste A. Faucheux [France] ; Marie-Elise Martin [France] ; Carole Beaumont [France] ; Stéphane Hunot [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease
003516 A. Hartmann [France] ; A. Mouatt-Prigent [France] ; B. A. Faucheux [France] ; Yves Agid [France] ; E. C. Hirsch [France]FADD: A link between TNF family receptors and caspases in Parkinson's disease
003517 Nina Rawal [France] ; Magali Periquet [France] ; Alexandra Dürr [France] ; Giuseppe De Michele [Italie] ; Vincenzo Bonifati [Italie] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Joao Guimaraes [Portugal] ; Yves Agid [France] ; Alexis Brice [France]Exclusion of the Nurr1 gene in autosomal recessive Parkinson's disease
003532 Luc Mallet [France] ; Valérie Mesnage [France] ; Jean-Luc Houeto [France] ; Antoine Pelissolo [France] ; Jérome Yelnik [France] ; Cécile Behar [France] ; Marcella Gargiulo [France] ; Marie-Laure Welter [France] ; Anne-Marie Bonnet [France] ; Bernard Pillon [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Bernard Pidoux [France] ; Jean-Francois Allilaire [France] ; Yves Agid [France]Compulsions, Parkinson's disease, and stimulation
003534 M. L. Welter [France] ; J. L. Houeto [France] ; S. Tezenas Du Montcel [France] ; V. Mesnage [France] ; A. M. Bonnet [France] ; B. Pillon [France] ; I. Arnulf [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France]Clinical predictive factors of subthalamic stimulation in Parkinson's disease
003542 Claire Borie [France] ; Francesca Gasparini [France] ; Patrice Verpillat [France] ; Anne-Marie Bonnet [France] ; Yves Agid [France] ; Gilles Hetet [France] ; Alexis Brice [France] ; Alexandra Dürr [France] ; Bernard Grandchamp [France]Association study between iron-related genes polymorphisms and Parkinson's disease
003547 B. P. Bejjani [Liban] ; J. L. Houeto [France] ; M. Hariz [Suède] ; J. Yelnik [France] ; V. Mesnage [France] ; A. M. Bonnet [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France]Aggressive behavior induced by intraoperative stimulation in the triangle of Sano
003583 A. Hartmann [France] ; J D Troadec ; S. Hunot ; K. Kikly ; B A Faucheux ; A. Mouatt-Prigent ; M. Ruberg ; Yves Agid [France] ; E C HirschCaspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.
003669 Marie-Paule Muriel [France] ; Yves Agid [France] ; Etienne Hirsch [France]Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease
003673 Martin Zarate-Lagunes [France] ; Wen-Jie Gu [France] ; Véronique Blanchard [France] ; Chantal Francois [France] ; Marie-Paule Muriel [France] ; Annick Mouatt-Prigent [France] ; Bruno Bonici [France] ; André Parent [France] ; Andreas Hartmann [France] ; Jérôme Yelnik [France] ; Georg A. Boehme [France] ; Laurent Pradier [France] ; Saliha Moussaoui [France] ; Baptiste Faucheux [France] ; Rita Raisman-Vozari [France] ; Yves Agid [France] ; Alexis Brice [France] ; Etienne C. Hirsch [France]Parkin immunoreactivity in the brain of human and non‐human primates: An immunohistochemical analysis in normal conditions and in Parkinsonian syndromes
003676 Magali Periquet ; Christoph B. Lücking ; Jenny R. Vaughan ; Vincenzo Bonifati ; Alexandra Dürr ; Giuseppe De Michele ; Martin W. Horstink [Pays-Bas] ; Matt Farrer ; Sergei N. Illarioshkin ; Pierre Pollak ; Michel Borg ; Christine Brefel-Courbon ; Patrice Denefle [France] ; Giuseppe Meco ; Thomas Gasser ; Monique M. B. Breteler [Pays-Bas] ; Nick W. Wood ; Yves Agid [France] ; Alexis Brice [France]Origin of the Mutations in the parkin Gene in Europe: Exon Rearrangements Are Independent Recurrent Events, whereas Point Mutations May Result from Founder Effects
003695 C. Marin [Espagne] ; A. Jiménez [Espagne] ; M. Bonastre [Espagne] ; M. Vila [France, États-Unis] ; Yves Agid [France] ; E. C. Hirsch [France] ; E. Tolosa [Espagne]LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa‐induced motor alterations in Parkinsonian rats
003747 Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Douhou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice
003797 Yves Agid [France] ; H. Dechy ; A. Destee ; P. Hinault ; E. Broussolle ; T. H. DechyAttitude pratique face aux complications de la L-dopathérapie chez les patients parkinsoniens fluctuants
003800 Philippe Damier [France] ; Jean-Luc Houeto [France] ; Boulos-Paul Bejjani [Liban] ; Isabelle Arnulf [France] ; Anne-Marie Bonnet [France] ; Malika Miloudy [France] ; Yves Agid [France]The role of the pallidum in Parkinson's disease: Gait lessons from pallidal stimulation
003817 Yves Agid [France]Levodopa: Is toxicity a myth?
003818 Andreas Hartmann [France] ; Patrick P. Michel [France] ; Jean-Denis Troadec [France] ; Annick Mouatt-Prigent [France] ; Baptiste A. Faucheux [France] ; Merle Ruberg [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
003828 O. Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France]Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
003839 S. Descombes [France] ; A. M. Bonnet [France] ; U. E. Gasser [Suisse] ; C. Thalamas [France] ; J. Dingemanse [Suisse] ; I. Arnulf [France] ; M. P. Bareille [France] ; Yves Agid [France] ; O. Rascol [France]Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease
003880 T. Zalla [France] ; A. Sirigu ; B. Pillon ; B. Dubois ; Yves Agid [France] ; J. GrafmanHow patients with Parkinson's disease retrieve and manage cognitive event knowledge.
003884 I. Arnulf [France] ; B P Bejjani ; L. Garma ; A M Bonnet ; P. Damier ; B. Pidoux ; D. Dormont ; P. Cornu ; J P Derenne ; Yves Agid [France]Effect of low and high frequency thalamic stimulation on sleep in patients with Parkinson's disease and essential tremor.
003886 Andreas Hartmann [France] ; Stéphane Hunot [France] ; Patrick P. Michel [France] ; Marie-Paule Muriel [France] ; Sheela Vyas [Royaume-Uni] ; Baptiste A. Faucheux [France] ; Annick Mouatt-Prigent [France] ; Hélène Turmel [France] ; Anu Srinivasan [États-Unis] ; Merle Ruberg [France] ; Gerard I. Evan [Royaume-Uni] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
003887 A. Mouatt-Prigent [France] ; J O Karlsson ; J. Yelnik ; Yves Agid [France] ; E C HirschCalpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's disease.
003996 N. Kubis ; B. A. Faucheux ; G. Ransmayr [Autriche] ; P. Damier ; C. Duyckaerts ; D. Henin ; B. Forette ; Y. Le Charpentier [France] ; J.-J. Hauw ; Yves Agid [France] ; E. C. HirschPreservation of midbrain catecholaminergic neurons in very old human subjects
003A10 Marie-Paule Muriel [France] ; Nathalie Lambeng [France] ; Frédéric Darios [France] ; Patrick P. Michel [France] ; Etienne C. Hirsch [France] ; Yves Agid [France] ; Merle Ruberg [France]Mitochondrial free calcium levels (Rhod‐2 fluorescence) and ultrastructural alterations in neuronally differentiated PC12 cells during ceramide‐dependent cell death
003A11 Etienne C. Hirsch [France] ; Céline Périer [France] ; Gaël Orieux [France] ; Chantal François [France] ; Jean Féger [France] ; Jér Ome Yelnik [France] ; Miquel Vila [France] ; Richard Levy [France] ; Eduardo S. Tolosa [Espagne] ; Concepcio Marin [Espagne] ; M. Trinidad Herrero [Espagne] ; José A. Obeso [Espagne] ; Yves Agid [France]Metabolic effects of nigrostriatal denervation in basal ganglia
003A16 Boulos-Paul Bejjani [France, Liban] ; Isabelle Arnulf [France] ; Sophie Demeret [France] ; Philippe Damier [France] ; Anne-Marie Bonnet [France] ; Jean-Luc Houeto [France] ; Yves Agid [France]Levodopa‐induced dyskinesias in Parkinson's disease: Is sensitization reversible?
003A33 J. Yelnik [France] ; P. Damier [France] ; B. P Bejjani [France] ; C. Francois [France] ; D. Gervais [France] ; D. Dormont [France] ; I. Arnulf [France] ; A. M. Bonnet [France] ; P. Cornu [France] ; B. Pidoux [France] ; Yves Agid [France]Functional mapping of the human globus pallidus: contrasting effect of stimulation in the internal and external pallidum in Parkinson’s disease
003A51 Caroline Jan [France] ; Chantal François [France] ; Dominique Tandé [France] ; Jérôme Yelnik [France] ; Léon Tremblay [France] ; Yves Agid [France] ; Etienne Hirsch [France]Dopaminergic innervation of the pallidum in the normal state, in MPTP‐treated monkeys and in parkinsonian patients
003A72 Annick Mouatt-Prigent [France] ; Jan-Olof Karlsson [Suède] ; Jerome Yelnik [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's disease
003A78 G. Ransmayr [Autriche] ; B. Faucheux [France] ; C. Nowakowski [Autriche] ; N. Kubis [France] ; S. Federspiel [Autriche] ; W. Kaufmann [Autriche] ; D. Henin [France] ; J.-J Hauw [France] ; Yves Agid [France] ; E. C Hirsch [France]Age-related changes of neuronal counts in the human pedunculopontine nucleus
003A95 Yves Agid [France]Une façon d'examiner un patient parkinsonien
003B60 J. L. Houeto [France] ; P. Damier [France] ; P. B. Bejjani [France] ; C. Staedler [France] ; A. M. Bonnet [France] ; I. Arnulf [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France]Subthalamic stimulation in Parkinson disease : A multidisciplinary approach
003B69 B. Pillon [France] ; C. Ardouin [France] ; P. Damier [France] ; P. Krack [France] ; J. L. Houeto [France] ; H. Klinger [France] ; A. M. Bonnet [France] ; P. Pollak [France] ; A. L. Benabid [France] ; Yves Agid [France]Neuropsychological changes between "off" and "on" STN or GPi stimulation in parkinson's disease
003B72 G. Orieux [France] ; C. Francois [France] ; J. Feger [France] ; J. Yelnik [France] ; M. Vila [France] ; M. Ruberg [France] ; Yves Agid [France] ; E. C. Hirsch [France]Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease
003B78 Boulos Paul Bejjani [France] ; Isabelle Arnulf [France] ; Marie Vidailhet [France] ; Bernard Pidoux [France] ; Philippe Damier [France] ; Savvas Papadopoulos [France] ; Anne-Marie Bonnet [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Yves Agid [France]Irregular jerky tremor, myoclonus, and thalamus : A study using low-frequency stimulation
003B79 C. Perier [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; J. Feger [France]Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion
003B81 I. Arnulf [France] ; B. P. Bejjani [France] ; L. Garma [France] ; A. M. Bonnet [France] ; J. L. Houeto [France] ; P. Damier [France] ; J. P. Derenne [France] ; Yves Agid [France]Improvement of sleep architecture in PD with subthalamic nucleus stimulation
003B82 S. Rivaud-Pechoux [France] ; A.-I. Vermersch [France] ; B. Gaymard [Allemagne] ; C. J. Ploner [Allemagne] ; B. P. Bejjani [Allemagne] ; P. Damier [Allemagne] ; S. Demeret [Allemagne] ; Yves Agid [France] ; C. Pierrot-Deseilligny [Allemagne]Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation
003B84 I. Arnulf [France] ; A.-M. Bonnet [France] ; P. Damier [France] ; B.-P. Bejjani [France] ; D. Seilhean [France] ; J.-P. Derenne [France] ; Yves Agid [France]Hallucinations, REM sleep, and Parkinson's disease : A medical hypothesis
003B87 C. Perier [France] ; M. Vila [France] ; J. Feger [France] ; Yves Agid [France] ; E. C. Hirsch [France]Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats
003B90 J. L. Houeto [France] ; P. B. Bejjani [France] ; P. Damier [France] ; C. Staedler [France] ; A. M. Bonnet [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [Liban]Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD
003B92 Pierre Dubus [France] ; Baptiste Faucheux [France] ; Florence Boissiere [France] ; Alexis Groppi [France] ; Claude Vital [France] ; T. Anne Vital [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] ; Jean Philippe Merlio [France]Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease
003C04 W.-J. Gu [France] ; N. Abbas [France] ; M. Z. Lagunes [France] ; A. Parent [France] ; L. Pradier [France] ; G. A. Bohme [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; R. Raisman-Vozari [France] ; A. Brice [France]Cloning of rat parkin cDNA and distribution of parkin in rat brain
003C07 B.-P. Bejjani [France, Liban] ; D. Dormont ; B. Pidoux ; J. Yelnik ; P. Damier ; I. Arnulf ; A.-M. Bonnet ; C. Marsault ; Yves Agid [France] ; J. Philippon ; P. CornuBilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance
003C08 B.-P. Bejjani [France, Liban] ; D. Gervais [France] ; I. Arnulf [France] ; S. Papadopoulos [France] ; S. Demeret [France] ; A.-M. Bonnet [France] ; P. Cornu [France] ; P. Damier [France] ; Yves Agid [France]Axial parkinsonian symptoms can be improved : The role of levodopa and bilateral subthalamic stimulation
003C09 C. B. Lücking [France] ; A. Dürr [France] ; V. Bonifati [Italie] ; J. Vaughan [Royaume-Uni] ; G. De Michele [Italie] ; T. Gasser [Allemagne] ; B. S. Harhangi [Pays-Bas] ; G. Meco [Italie] ; P. Denefle [France] ; N. W. Wood [Royaume-Uni] ; Yves Agid [France] ; A. Brice [France]Association between early-onset Parkinson's disease and mutations in the Parkin gene
003C30 D. Brassat [France] ; A. Durr ; Yves Agid [France] ; A. Brice[Genetics of Parkinson disease].
003C37 M. Vidailhet [France] ; S. Rivaud ; N. Gouider-Khouja ; B. Pillon ; B. Gaymard ; Yves Agid [France] ; C. Kennard ; C. Pierrot-DeseillignySaccades and antisaccades in parkinsonian syndromes.
003C50 Yves Agid [France] ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; Werner Poewe [Autriche] ; P. Pollak ; E. TolosaLevodopa in the treatment of Parkinson's disease: a consensus meeting.
003C52 E C Hirsch [France] ; S. Hunot ; P. Damier ; B. Brugg ; B A Faucheux ; P P Michel ; M. Ruberg ; M P Muriel ; A. Mouatt-Prigent ; Yves Agid [France]Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease.
003C53 S. Hunot [France] ; N. Dugas ; B. Faucheux ; A. Hartmann ; M. Tardieu ; P. Debré ; Yves Agid [France] ; B. Dugas ; E C HirschFcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.
003D07 Baptiste A. Faucheux [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] ; Anne-Marie BonnetBlood vessels change in the mesencephalon of patients with Parkinson's disease
003D14 Nacer Abbas [France] ; Christoph B. Lücking [France] ; Sylvain Ricard [France] ; Alexandra Dürr [France] ; Vincenzo Bonifati [Italie] ; Giuseppe De Michele [Italie] ; Sandrine Bouley [France] ; Jenny R. Vaughan [Royaume-Uni] ; Thomas Gasser [Allemagne] ; Roberto Marconi [Italie] ; Emmanuel Broussolle [France] ; Christine Brefel-Courbon [France] ; Biswadjiet S. Harhangi [Pays-Bas] ; Ben A. Oostra [Pays-Bas] ; Edito Fabrizio [Italie] ; Georg A. Böhme [France] ; Laurent Pradier [France] ; Nick W. Wood [Royaume-Uni] ; Alessandro Filla [Italie] ; Giuseppe Meco [Italie] ; Patrice Denefle [France] ; Yves Agid [France] ; Alexis Brice [France]A Wide Variety of Mutations in the Parkin Gene Are Responsible for Autosomal Recessive Parkinsonism in Europe
003D35 D. Brassat [France] ; A. Durr [France] ; Yves Agid [France] ; A. Brice [France]Génétique de la maladie de Parkinson
003D63 P. Damier [France, États-Unis] ; E. C. Hirsch [France] ; Yves Agid [France] ; A. M. Graybiel [États-Unis]The substantia nigra of the human brain
003D88 Yves Agid [France]Parkinson's disease or Parkinson's diseases?
003D97 Nathalie Lambeng [France] ; Patrick P. Michel [France] ; Bernard Brugg [France] ; Yves Agid [France] ; Merle Ruberg [France]Mechanisms of apoptosis in PC12 cells irreversibly differentiated with nerve growth factor and cyclic AMP
003D98 Marie-Paule Muriel [France] ; Véronique Bernard [France] ; Allan I. Levey [États-Unis] ; Ouahiba Laribi [France] ; D. Nora Abrous [France] ; Yves Agid [France] ; Bertrand Bloch [France] ; Etienne C. Hirsch [France]Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease
003E77 F. Durif [France] ; M. Vidailhet [France] ; B. Debilly [France] ; Yves Agid [France]Worsening of levodopa-induced dyskinesias by motor and mental tasks
003E80 B.-P. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; L. Thivard [France] ; A.-M. Bonnet [France] ; D. Dormont [France] ; P. Cornu [France] ; B. Pidoux [France] ; Y. Samson [France] ; Yves Agid [France]Transient acute depression induced by high-frequency deep-brain stimulation
003E83 M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France]The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
003E86 M. Vila [France] ; C. Marin [Espagne] ; M. Ruberg [France] ; A. Jimenez [Espagne] ; R. Raisman-Vozari [France] ; Yves Agid [France] ; E. Tolosa [Espagne] ; E. C. Hirsch [France]Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia
003E89 K. Parain [France] ; M. G. Murer [France] ; QIAO YAN [États-Unis] ; B. Faucheux [France] ; Yves Agid [France] ; E. Hirsch [France] ; R. Raisman-Vozari [France]Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra
003F18 P. Damier [France] ; C. Jaillon [France] ; I. Clavier [France] ; I. Arnulf [France] ; A.-M. Bonnet [France] ; B.-P. Bejjani [France] ; Yves Agid [France]Dyskinesias assessment in phase II studies
003F25 N. Sabbagh [France] ; A. Brice [France] ; D. Marez [France] ; A. Dürr [France] ; M. Legrand [France] ; J.-M. Lo Guidice [France] ; A. Destee [France] ; Yves Agid [France] ; F. Broly [France]CYP2D6 polymorphism and Parkinson's disease susceptibility
003F26 C. Ardouin [France] ; B. Pillon [France] ; E. Peiffer [France] ; P. Bejjani [France] ; P. Limousin [France] ; P. Damier [France] ; I. Arnulf [France] ; A. L. Benabid [France] ; Yves Agid [France] ; P. Pollak [France]Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions : A consecutive series of 62 patients
003F30 P. P. Michel [France] ; M. Marien [France] ; M. Ruberg [France] ; F. Colpaert [France] ; Yves Agid [France]Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes
003F31 M. A. Bedard [Canada] ; B. Pillon [France] ; B. Dubois [France] ; N. Duchesne [Canada] ; H. Masson [Canada] ; Yves Agid [France]Acute and long-term administration of anticholinergics in Parkinson's disease : Specific effects on the subcortico-frontal syndrome
003F50 C. Dumanchin [France] ; A. Camuzat ; D. Campion ; P. Verpillat ; D. Hannequin ; B. Dubois ; P. Saugier-Veber ; C. Martin ; C. Penet ; F. Charbonnier ; Yves Agid [France] ; T. Frebourg ; A. BriceSegregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism.
003F58 Yves Agid [France] ; T. Chase ; D. MarsdenAdverse reactions to levodopa: drug toxicity or progression of disease?
003F59 S. Benisty [France] ; F. Boissiere [France] ; B. Faucheux [France] ; Yves Agid [France] ; E. C Hirsch [France]Tyrosine kinase B messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study
003F69 Jenny R. Vaughan [Royaume-Uni] ; Matthew J. Farrer [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Thomas Gasser [Allemagne] ; Alexandra Durr [France] ; Yves Agid [France] ; Vincenzo Bonifati [Italie] ; Giuseppe Demichele [Italie] ; Gianpiero Volpe [Italie] ; Sarah Lincoln [États-Unis] ; Monique Breteler [Pays-Bas] ; Giuseppe Meco [Italie] ; Alexis Brice [France] ; C. David Marsden [Royaume-Uni] ; John Hardy [États-Unis] ; Nicholas W. Wood [Royaume-Uni]Sequencing of the α-Synuclein Gene in a Large Series of Cases of Familial Parkinson's Disease Fails to Reveal any Further Mutations
003F93 T. Zalla [France] ; A. Sirigu [France] ; B. Pillon [France] ; B. Dubois [France] ; J. Grafman [États-Unis] ; Yves Agid [France]Deficit in Evaluating Pre-Determinated Sequences of Script Events in Patients with Parkinson's Disease
004028 Joao Villares [France] ; Baptiste Faucheux [France] ; Maria T. Herrero [Espagne] ; Jose A. Obeso [Espagne] ; Charles Duyckaerts [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France][125I]EGF Binding in Basal Ganglia of Patients with Parkinson's Disease and Progressive Supranuclear Palsy and in MPTP-Treated Monkeys
004036 Jenny Vaughan [Royaume-Uni] ; Alexandra Durr [France] ; Johann Tassin [France] ; Benjamin Bereznai [Allemagne] ; Thomas Gasser [Allemagne] ; Vincenzo Bonifati [Italie] ; Giuseppe De Michele [Italie] ; Edito Fabrizio [Italie] ; Gianpiero Volpe [Italie] ; O. Bandmann [Royaume-Uni] ; William G. Johnson [États-Unis] ; Lawrence I. Golbe [États-Unis] ; Monique Breteler [Pays-Bas] ; Giuseppe Meco [France] ; Yves Agid [France] ; Alexis Brice [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; C. David Wood [Royaume-Uni]The α‐synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases
004049 Marie Vidailhet [France] ; Charles-Pierre Jedynak [France] ; Pierre Pollak [France] ; Yves Agid [France]Pathology of Symptomatic Tremors
004090 Johann Tassin ; Alexandra Dürr ; Thomas De Broucker [France] ; Nacer Abbas ; Vincenzo Bonifati ; Giuseppe De Michele ; Anne-Marie Bonnet ; Emmanuel Broussolle ; Pierre Pollak [France] ; Marie Vidailhet ; Michele De Mari [Italie] ; Roberto Marconi [Italie] ; Soraya Medjbeur ; Allessandro Filla ; Giuseppe Meco ; Yves Agid [France] ; Alexis Brice [France]Chromosome 6–Linked Autosomal Recessive Early-Onset Parkinsonism: Linkage in European and Algerian Families, Extension of the Clinical Spectrum, and Evidence of a Small Homozygous Deletion in One Family
004099 Irene Litvan [États-Unis] ; Joseph Jankovic [États-Unis] ; Christopher G. Goetz [États-Unis] ; Gregory K. Wenning [Royaume-Uni] ; Narahary Sastry [États-Unis] ; Kurt Jellinger [Autriche] ; Ann Mckee [États-Unis] ; Eugene C. Lai [États-Unis] ; Jean-Philippe Brandel [France] ; Marc Verny [France] ; K. Ray-Chaudhuri [Royaume-Uni] ; Ron K. B. Pearce [Royaume-Uni] ; John J. Bartko [États-Unis] ; Yves Agid [France]Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study
004121 M. Vidailhet [France] ; A.-M. Bonnet [France] ; Yves Agid [France]Critères cliniques de diagnostic des atrophies multi-systématisées
004129 S. Benisty [France] ; F. Boissiere [France] ; B. Faucheux [France] ; Yves Agid [France] ; E. C. Hirsch [France]trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients : An in situ hybridization study
004130 J. Villares [France, Brésil] ; B. Faucheux [France] ; M. T. Herrero [Espagne] ; J. A. Obeso [Espagne] ; C. Duyckaerts [France] ; J.-J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France][125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys
004142 S. Pol [France] ; M. Vidailhet [France] ; S. Meunier [France] ; D. Mazevet [France] ; Yves Agid [France] ; E. Pierrot-Deseilligny [France]Overactivity of cervical premotor neurons in Parkinson's disease
004149 Yves Agid [France]Levodopa : Is toxicity a myth?
004166 B.-P. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; S. Papadopoulos [France] ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France] ; B. Pidoux [France] ; P. Cornu [France] ; D. Dormont [France] ; C. Marsault [France]Deep brain stimulation in Parkinson's disease : Opposite effects of stimulation in the pallidum
004171 M.-A. Bedard [Canada] ; F. El Massioui [France] ; C. Malapani [France] ; B. Dubois [France] ; B. Pillon [France] ; B. Renault [France] ; Yves Agid [France]Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist
004173 I. Litvan [États-Unis] ; A. Macintyre [États-Unis] ; C. G. Goetz [États-Unis] ; G. K. Wenning [Royaume-Uni] ; K. Jellinger [Autriche] ; M. Verny [France] ; J. J. Bartko [États-Unis] ; Joseph Jankovic [États-Unis] ; A. Mckee [États-Unis] ; J. P. Brandel [France] ; K. R. Chaudhuri [Royaume-Uni] ; E. C. Lai [États-Unis] ; L. D'Olhaberriague [États-Unis] ; R. K. B. Pearce [Royaume-Uni] ; Yves Agid [France]Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies : A clinicopathologic study
004198 Stephane Hunot ; Bernard Brugg ; Damien Ricard ; Patrick P. Michel ; Marie-Paule Muriel ; Merle Ruberg ; Baptiste A. Faucheux ; Yves Agid [France] ; Etienne C. HirschNuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease
004199 E C Hirsch [France] ; B. Faucheux ; P. Damier ; A. Mouatt-Prigent ; Yves Agid [France]Neuronal vulnerability in Parkinson's disease.
004205 M. Vila [France] ; R. Levy ; M T Herrero ; M. Ruberg ; B. Faucheux ; J A Obeso ; Yves Agid [France] ; E C HirschConsequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
004207 P. Anglade [France] ; S. Vyas ; F. Javoy-Agid ; M T Herrero ; P P Michel ; J. Marquez ; A. Mouatt-Prigent ; M. Ruberg ; E C Hirsch ; Yves Agid [France]Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
004281 M. Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France]Urinary disturbances in striatonigral degeneration and parkinson's disease: Clinical and urodynamic aspects
004286 Baptiste A. Faucheux [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease
004383 M. Ruberg [France] ; V. France-Lanord [France] ; B. Brugg [France] ; N. Lambeng [France] ; P. P. Michel [France] ; P. Anglade [France] ; S. Hunot [France] ; P. Damier [France] ; B. Faucheux [France] ; E. Hirsch [France] ; Yves Agid [France]La mort neuronale par apoptose dans la maladie de Parkinson
004406 I. Litvan [États-Unis] ; C. G. Goetz [États-Unis] ; Joseph Jankovic [États-Unis] ; G. K. Wenning [Royaume-Uni] ; V. Booth [États-Unis] ; J. J. Bartko [États-Unis] ; A. Mckee [États-Unis] ; K. Jellinger [Autriche] ; E. C. Lai [États-Unis] ; J.-P. Brandel [France] ; M. Verny [France] ; K. R. Chaudhuri [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni] ; Yves Agid [France]What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study
004407 A. M. Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France]Urinary disturbances in striatonigral degeneration and Parkinson's disease: Clinical and urodynamic aspects
004408 Yves Agid [France] ; A. Destee ; F. Durif ; J.-L. Montastruc ; P. PollakTolcapone, bromocriptine, and Parkinson's disease
004417 P. P. Michel [France] ; M. Ruberg [France] ; Yves Agid [France]Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside
004418 R. Levy [France] ; L.-N. Hazrati [Canada] ; M.-T. Herrero [France, Espagne] ; M. Vila [France] ; O.-K. Hassani [France] ; M. Mouroux [France] ; M. Ruberg [France] ; H. Asensi [Espagne] ; Yves Agid [France] ; J. Feger [France] ; J. A. Obeso [Espagne] ; A. Parent [Canada] ; E. C. Hirsch [France]Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states
004422 B. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; A. M. Bonnet [France] ; M. Vidailhet [France] ; D. Dormont [France] ; B. Pidoux [France] ; P. Cornu [France] ; C. Marsault [France] ; Yves Agid [France]Pallidal stimulation for Parkinson's disease : Two targets?
004425 V. France-Lanord [France] ; B. Brugg [France] ; P. P. Michel [France] ; Yves Agid [France] ; M. Ruberg [France]Mitochondrial free radical signal in ceramide-dependent apoptosis : A putative mechanism for neuronal death in Parkinson's disease
004428 F. Durif [France] ; M. Vidailhet [France] ; F. Assal [France] ; C. Roche [France] ; A. M. Bonnet [France] ; Yves Agid [France]Low-dose clozapine improves dyskinesias in Parkinson's disease
004431 M. Ruberg [France] ; B. Brugg [France] ; A. Prigent [France] ; E. Hirsch [France] ; A. Brice [France] ; Yves Agid [France]Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?
004439 S. Vyas [France] ; F. Javoy-Agid [France] ; M.-T. Herrero [Espagne] ; O. Strada [France] ; F. Boissiere [France] ; U. Hibner [France] ; Yves Agid [France]Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders
004455 C. Adelbrecht [France] ; M. G. Murer [France] ; I. Lauritzen [France] ; F. Lesage [France] ; M. Ladzunski [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalon
004457 I. Litvan [États-Unis] ; Yves Agid [France] ; C. Goetz [États-Unis] ; Joseph Jankovic [États-Unis] ; G. K. Wenning [Royaume-Uni] ; J. P. Brandel [France] ; E. C. Lai [États-Unis] ; M. Verny [France] ; K. Ray-Chaudhuri [Royaume-Uni] ; A. Mckee [États-Unis] ; K. Jellinger [Autriche] ; R. K. B. Pearce [Royaume-Uni] ; J. J. Bartko [États-Unis]Accuracy of the clinical diagnosis of corticobasal degeneration : A clinicopathologic study
004477 P. Anglade [France] ; V. Blanchard ; R. Raisman-Vozari ; B A Faucheux ; M T Herrero ; J A Obeso ; A. Mouatt-Prigent ; A. Kastner ; O. Strada ; F. Javoy-Agid ; Yves Agid [France] ; E C HirschIs dopaminergic cell death accompanied by concomitant nerve plasticity?
004482 A. Partiot [France] ; M. Vérin ; B. Pillon ; C. Teixeira-Ferreira ; Yves Agid [France] ; B. DuboisDelayed response tasks in basal ganglia lesions in man: further evidence for a striato-frontal cooperation in behavioural adaptation.
004505 Bernard Pillon [France] ; Stephane Ertle [France] ; Bernard Deweer [France] ; Marie Sarazin [France] ; Yves Agid [France] ; Bruno Dubois [France]Memory for spatial location is affected in Parkinson's disease
004518 M. T. Herrero [Espagne] ; S. J. Augood [Royaume-Uni] ; H. Asensi [Espagne] ; E. C. Hirsch [France] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson [Royaume-Uni]Effects of l-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys
004561 Philippe Anglade [France] ; Annick Mouatt-Prigent [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Synaptic Plasticity in the Caudate Nucleus of Patients with Parkinson's Disease
004565 A I Vermersch [France] ; R M Müri [France] ; S. Rivaud [France] ; M. Vidailhet [France] ; B. Gaymard [France] ; Yves Agid [France] ; C. Pierrot-Deseilligny [France]Saccade disturbances after bilateral lentiform nucleus lesions in humans.
004571 M. Verny ; K. A. Jellinger ; J.-J. Hauw ; C. Bancher ; I. Litvan [États-Unis] ; Yves Agid [France]Progressive supranuclear palsy: a clinicopathological study of 21 cases
004579 S. Hunot [France] ; F. Boissière [France] ; B. Faucheux [France] ; B. Brugg [France] ; A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. Hirsch [France]Nitric oxide synthase and neuronal vulnerability in parkinson's disease
004586 M. Vila [France] ; R. Levy [France] ; M.-T. Herrero [Espagne] ; B. Faucheux [France] ; J. A. Obeso [Espagne] ; Yves Agid [France] ; E. C. Hirsch [France]Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study
004595 A. Mouatt-Prigent [France] ; J. O. Karlsson [Suède] ; Yves Agid [France] ; E. C. Hirsch [France]Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?
004603 S. Hunot [France] ; V. Bernard [France] ; B. Faucheux [France] ; F. Boissière [France] ; E. Leguern [France] ; C. Brana [France] ; P. P. Gautris [France] ; J. Guérin [France] ; B. Bloch [France] ; Yves Agid [France] ; E. C. Hirsch [France]Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: A post mortem in situ hybridization study with special reference to Parkinson's disease
004609 Veronique Bernard [France] ; Alejandra Gardiol [France] ; Baptiste Faucheux [France] ; Bertrand Bloch [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Expression of glutamate receptors in the human and rat basal ganglia: Effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in parkinson's disease and rat with 6‐OHDA lesion
004619 M. Chritin ; V. Blanchard [France] ; R. Raisman-Vozari [France] ; C. Feuerstein ; Yves Agid [France] ; F. Javoy-Agid [France] ; M. SavastaDA Uptake Sites, D1, and D2 Receptors, D2 and Preproenkephalin mRNAs and Fos Immunoreactivity in Rat Striatal Subregions after Partial Dopaminergic Degeneration
004623 J. L. Pezzoli [Italie] ; O. Strada [Italie] ; V. Silani [Italie] ; A. Zecchinelli [Italie] ; L. Perbellini [France] ; F. Javoy-Agid [Italie] ; P. Ghidoni [Italie] ; E. D. F. Motti [Italie] ; T. Masini [Italie] ; G. Scarlato [Italie] ; Yves Agid [Italie] ; E. C. Hirsch [Italie]Clinical and pathological features in hydrocarbon‐induced Parkinsonism
004624 B. Leveugle [États-Unis] ; B. A. Faucheux ; C. Bouras [États-Unis] ; N. Nillesse ; G. Spik ; E. C. Hirsch ; Yves Agid [France] ; P. R. Hof [États-Unis]Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson’s disease cases
004658 J. Guridi [Espagne] ; M. T. Herrero ; M. R. Luquin ; J. Guillen ; M. Ruberg ; J. Laguna ; M. Vila ; F. Javoy-Agid ; Yves Agid [France] ; E. Hirsch ; J. A. ObesoSubthalamotomy in parkinsonian monkeys : Behavioural and biochemical analysis
004665 A. F. Carpentier [France] ; A. M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France]Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease
004669 C. Adelbrecht [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area
004671 P. Damier [France] ; A. Kastner [France] ; Yves Agid [France] ; E. C. Hirsch [France]Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease ?
004674 M. Vila [France] ; M. T. Herrero ; R. Levy [France] ; B. Faucheux [France] ; M. Ruberg [France] ; J. Guillen ; M. R. Luquin ; J. Guridi ; F. Javoy-Agid [France] ; Yves Agid [France] ; J. A. Obeso ; E. C. Hirsch [France]Consequences of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes
004676 P. P. Michel [France] ; Yves Agid [France]Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons
004678 B. Brugg [France] ; P. P. Michel ; Yves Agid [France] ; M. RubergCeramide induces apoptosis in cultured mesencephalic neurons
004697 B A Faucheux ; N. Nillesse ; P. Damier ; G. Spik ; A. Mouatt-Prigent ; A. Pierce ; B. Leveugle ; N. Kubis ; J J Hauw ; Yves Agid [France]Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.
004715 Richard Levy [France] ; Miquel Vila [France] ; Maria-Trinidad Herrero [Espagne] ; Baptiste Faucheux [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Striatal expression of substance P and methionin-enkephalin genes in patients with Parkinson's disease
004742 J. Blin [France] ; P. Mazetti [France] ; B. Mazoyer [France] ; S. Rivaud [France] ; S. Ben Ayed [France] ; C. Malapani [France] ; B. Pillon [France] ; Yves Agid [France]Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?
004778 Stéphane Gouider-Khouja [France] ; Marie Vidailhet [France] ; Anne-Marie Bonnet [France] ; Jacques Pichon [France] ; Yves Agid [France]“Pure” striatonigral degeneration and Parkinson's disease: A comparative clinical study
004785 Patrick P. Michel [France] ; Sheela Vyas [France] ; Yves Agid [France]Synergistic Differentiation by Chronic Exposure to Cyclic AMP and Nerve Growth Factor Renders Rat Phaeochromocytoma PC12 Cells Totally Dependent upon Trophic Support for Survival
004825 R. Levy [France] ; M. T. Herrero [France, Espagne] ; M. Ruberg [France] ; J. Villares [France] ; B. Faucheux [France] ; J. Guridi [Espagne] ; J. Guillen [Espagne] ; M. R. Luquin [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [France] ; E. C. Hirsch [France]Effects of Nigrostriatal Denervation and L‐Dopa Therapy on the GABAergic Neurons of the Striatum in MPTP‐treated Monkeys and Parkinson's Disease: An In Situ Hybridization Study of GAD67 mRNA
004831 P. P. Michel [France] ; Yves Agid [France]Death of septal cholinergic neurons produced by chronic exposure to glutamate is prevented by the noncompetitive NMDA receptor/channel antagonist, MK‐801: Role of nerve growth factor and nitric oxide
004837 Reshef Campion [France] ; M. Martinez [France] ; D. Hannequin [France] ; A. Brice [France] ; C. Thomas-Anterion [France] ; A. Michon [France] ; M. C. Babron [France] ; B. Dubois [France] ; Y. Goas [France] ; A. Jaillard-Serradt [France] ; F. Ledoze [France] ; F. Pasquier [France] ; M. Puel [France] ; M. A. Zimmerman [France] ; M. Bellis [France] ; J. Mallet [France] ; Yves Agid [France] ; F. Clerget-Darpoux [France]Characteristics of familial aggregation in early‐onset Alzheimer's disease: Evidence of subgroups
004842 B. A. Faucheux [France] ; M. T. Herrero [Espagne] ; J. Villares [France] ; R. Levy [France] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France]Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys
004847 M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France]A “combined” levodopa test as a useful method for evaluating the efficacy of dopamine agonists: Application to pergolide and bromocriptine
004861 Yves Agid [France] ; L. Montagnier ; M. Bourel ; G. Serratrice ; R. Nordmann ; G. Blancher ; C. Pilet ; M.-O. Mme Rethore ; H. Lestradet ; J. Polonovski ; H. Bouissou ; P. Lefebvre ; J.-L. De GennesLe vieillissement, la maladie et la mort des cellules nerveuses. Discussion
004876 F. Thibaut [France] ; B. A. Faucheux [France] ; J. Marquez [France] ; J. Villares [France] ; J. F. Menard [France] ; Yves Agid [France] ; E. C. Hirsch [France]Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease : a postmortem study using tritiated tetrabenazine
004881 B. Pillon [France] ; N. Gouider-Khouja ; B. Deweer ; M. Vidailhet ; C. Malapani ; B. Dubois ; Yves Agid [France]Neuropsychological pattern of striatonigral degeneration : comparison with Parkinson's disease and progressive supranuclear palsy
004886 V. Blanchard [France] ; M. Chritin ; SHEELA VYAS [France] ; M. Savasta ; C. Feuerstein ; Yves Agid [France] ; F. Javoy-Agid [France] ; R. Raisman-Vozari [France]Long-term induction of tyrosine hydroxylase expression : compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain
004887 F. Durif [France] ; M. Vidailhet ; A. M. Bonnet ; J. Blin ; Yves Agid [France]Levodopa-induced dyskinesias are improved by fluoxetine
004891 M.-T. Herrero [Espagne] ; S. J. Augood ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; M. R. Luquin [Espagne] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. EmsonEffects of L-DOPA on preproenkephalin and preprotackykinin gene expression in the MPTP-treated monkey striatum
004893 M. Ruberg [France] ; D. Scherman [France] ; F. Javoy-Agid [France] ; Yves Agid [France]Dopamine denervation, age on onset, and Parkinson's disease
004901 A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France]A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine
004902 N. Gouider-Khouja [France] ; M. Vidailhet [France] ; A.-M. Bonnet [France] ; J. Pichon [France] ; Yves Agid [France]"Pure" striatonigral degeneration and Parkinson's disease : a comparative clinical study
004916 P P Michel [France] ; S. Vyas ; P. Anglade ; M. Ruberg ; Yves Agid [France]Morphological and molecular characterization of the response of differentiated PC12 cells to calcium stress.
004987 Sophie Holemans [Belgique] ; France Javoy-Agid [France] ; Yves Agid [France] ; Freddy De Paermentier [Royaume-Uni] ; E. Christian Laterre [Belgique] ; Jean-Marie Maloteaux [Belgique]Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease
004A06 Stéphane Lehéricy [France] ; Jean-Philippe Brandel [France] ; Etienne C. Hirsch [France] ; Philippe Anglade [France] ; Joao Villares [France] ; Daniel Scherman [France] ; Charles Duyckaerts [France] ; France Javoy-Agid [France] ; Yves Agid [France]Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography
004A20 Marie Vidailhet [France] ; Sophie Rivaud [France] ; Neziha Gouider-Khouja [France] ; Bernard Pillon [France] ; Anne-Marie Bonnet [France] ; Bertrand Gaymard [France] ; Yves Agid [France] ; Yves Pierrot-Deseilligny [France]Eye movements in parkinsonian syndromes
004A28 Annick Mouatt-Prigent [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
004A30 Chaodong Kastner [France] ; M. T. Herrero [France, Espagne] ; E. C. Hirsch [France] ; J. Guillen [Espagne] ; M. R. Luquin [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [France]Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP–intoxicated monkeys: Effect of levodopa and GM1 ganglioside therapy
004A43 Jeswinder Sian [Royaume-Uni] ; David T. Dexter [Royaume-Uni] ; Andrew J. Lees [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; Yves Agid [France] ; France Javoy-Agid [France] ; Peter Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni]Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
004A74 A.-I. Vermersch [France] ; S. Rivaud ; M. Vidailhet ; A.-M. Bonet ; B. Gaymard ; Yves Agid [France] ; C. Pierrot-DeseillignySequences of memory-guided saccades in Parkinson's disease
004A79 J. Villares [France] ; O. Strada ; B. Faucheux ; F. Javoy-Agid ; Yves Agid [France] ; E. C. HirschLoss of striatal affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease
004A81 C. Malapani [France] ; B. Pillon ; B. Dubois ; Yves Agid [France]Impaired simultaneous cognitive task performance in Parkinson's disease : a dopamine-related dysfunction
004A82 G. Boka [France] ; P. Anglade [France] ; D. Wallach ; F. Javoy-Agid [France] ; Yves Agid [France] ; E. C. Hirsch [France]Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
004A87 A. Kastner [France] ; M. T. Herrero [France] ; E. C. Hirsch [France] ; J. Guillen ; M. R. Luquin ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France]Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys : effect of levodopa and GM1 ganglioside therpay
004A91 B. Pillon [France] ; B. Deweer ; A. Michon ; C. Malapani ; Yves Agid [France] ; B. DuboisAre explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits ? : Comparison with Alzheimer's, Parkinson's, and Huntington's diseases
004B10 B A Faucheux [France] ; E C Hirsch ; J. Villares ; F. Selimi ; A. Mouatt-Prigent ; F. Javoy-Agid ; J J Hauw ; Yves Agid [France]Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.
004B56 B. Dubois [France] ; B. Pillon [France] ; Yves Agid [France]Détérioration des voies dopaminergiques et altérations des fonctions cognitives et motrices
004B63 A. Kastner [France] ; E. C. Hirsch [France] ; Yves Agid [France] ; F. Javoy-Agid [France]Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease
004B88 M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin [Espagne] ; J. Laguna [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [Espagne]Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
004B89 M. T. Herrero [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [France]Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum
004B91 Patrick Vermersch ; Patrick Delacourte [France] ; France Javoy-Agid [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France]Dementia in Parkinson's disease: Biochemical evidence for cortical involvement using the immunodetection of abnormal tau proteins
004B98 Joao Villares [France] ; Baptiste Faucheux [France] ; Ornella Strada [France] ; Etienne C. Hirsch [France] ; Yves Agid [France] ; France Javoy-Agid [France]Autoradiographic study of [125Iepidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem
004C13 Yves Agid [France]Mécanisme de la mort cellulaire dans les affections neurodégénératives : à propos de la maladie de Parkinson
004C48 O. Strada [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; C. Duyckaerts [France] ; J.-J. Hauw [France] ; Yves Agid [France]Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease
004C53 A. Kastner [France] ; E. C. Hirsch ; M. T. Herrero ; F. Javoy-Agid ; Yves Agid [France]Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease
004C54 P. Damier [France] ; E. C. Hirsch ; P. Zhang ; Yves Agid [France] ; F. Javoy-AgidGlutathione peroxidase, glial cells and Parkinson's disease
004C55 M.-T. Herrero [France] ; A. Kastner [France] ; I. Perez-Otano ; E. C. Hirsch [France] ; M.-R. Luquin ; F. Javoy-Agid [France] ; J. Del Rio ; J. A. Obeso ; Yves Agid [France]Gangliosides and parkinsonism
004C56 M. T. Herrero [France] ; I. Perez-Otano ; C. Oset ; A. Kastner [France] ; E. C. Hirsch [France] ; Yves Agid [France] ; M. R. Luquin ; J. A. Obeso ; J. Del RioGM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys
004C57 B. Pillon [France] ; B. Deweer ; Yves Agid [France] ; B. DuboisExplicit memory in Alzheimer's, Huntington's, and Parkinson's diseasees
004C63 B. A. Faucheux [France] ; E. C. Hirsch [France] ; J. Villares [France] ; F. Selimi [France] ; A. Mouatt-Prigent [France] ; F. Javoy-Agid [France] ; J. J. Hauw [France] ; Yves Agid [France]Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease
004C67 Yves Agid [France] ; M. Ruberg ; F. Javoy-Agid ; E. Hirsch ; R. Raisman-Vozari ; S. Vyas ; B. Faucheux ; P. Michel ; A. Kastner ; V. Blanchard ; P. Damier ; J. Villares ; PING ZHANGAre dopaminergic neurons selectively vulnerable to Parkinson's disease ?
004D14 Etiennec. Hirsch [France] ; Annick Mouatt [France] ; Baptiste Faucheux [France] ; Anne-Marie Bonnet [France] ; France Javoy-Agid [France] ; Annm. Graybiel [États-Unis] ; Yves Agid [Royaume-Uni]Dopamine, tremor, and Parkinson's disease
004D71 Robert Emre [Suisse] ; U. K. Rinne [Finlande] ; A. Rascol [France] ; A. Lees [Royaume-Uni] ; Yves Agid [France] ; X. Lataste [Suisse]Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease
004D75 B. Dubois [France] ; B. Pillon [France] ; Yves Agid [France]Deterioration of dopaminergic pathways and alterations in cognition and motor functions
004E30 P. P. Michel [France] ; S. Vyas ; Yves Agid [France]Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains
004E32 P. P. Michel [France] ; Yves Agid [France]The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures
004E38 A. Kastner [France] ; E. C. Hirsch ; O. Lejeune ; F. Javoy-Agid ; O. Rascol [France] ; Yves Agid [France]Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content ?
004E52 B. Pillon [France] ; B. Dubois ; Yves Agid [France]Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
004E53 E C Hirsch [France] ; J P Brandel ; P. Galle ; F. Javoy-Agid ; Yves Agid [France]Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
004E78 Yves Agid [France]Parkinson's disease: pathophysiology
004F03 D. T. Dexter [Royaume-Uni] ; A. Carayon [France] ; F. Javoy-Agid [France] ; Yves Agid [France] ; F. R. Wells [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; A. J. Lees [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA
004F15 Sophie Holemans [Belgique] ; France Javoy [France] ; Yves Agid [France] ; E. Christian Laterre [Belgique] ; Jean-Marie Maloteaux [Belgique][3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy
004F88 S. Holemans [Belgique] ; F. Javoy [France] ; Yves Agid [France] ; E. C. Laterre ; J.-M. Maloteaux[3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy
004F92 B. Pillon ; B. Dubois ; A. Ploska ; Yves Agid [France]Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy
004F96 E. C. Hirsch [France] ; J.-P. Brandel ; P. Galle ; F. Javoy-Agid ; Yves Agid [France]Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease : an X-ray microanalysis
004F99 J. Blin [France] ; B. Dubois ; A. M. Bonnet ; M. Vidailhet ; M. Brandabur ; Yves Agid [France]Does ageing aggravate Parkinsonian disability ?
005008 Yves Agid [France] ; A M Graybiel ; M. Ruberg ; E. Hirsch ; J. Blin ; B. Dubois ; F. Javoy-AgidThe efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
005017 I. Ceballos [France] ; M. Lafon [France] ; F. Javoy-Agid [France] ; E. Hirsch [France] ; A. Nicole [Royaume-Uni] ; P. M. Sinet [Royaume-Uni] ; Yves Agid [Royaume-Uni]Superoxide dismutase and Parkinson's disease
005020 M. J. Vidailhet [Royaume-Uni] ; A. M. Bonnet [Royaume-Uni] ; S. Belal [Royaume-Uni] ; B. Dubois [Royaume-Uni] ; C. Marle [Royaume-Uni] ; Yves Agid [Royaume-Uni]Ropinirole without levodopa in Parkinson's disease
005074 F. Thibaut [France] ; E. C. Hirsch [France] ; R. Raisman [France] ; F. Javoy-Agid [France] ; Yves Agid [France]Microtopography of d1 dopaminergic binding sites in the human substantia nigra: An autoradiographic study
005076 R. Raisman-Vozari [France] ; J.-A. Girault [États-Unis] ; S. Moussaoui [France] ; C. Feuerstein [France] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Yves Agid [France]Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man
005086 E. C. Hirsch [France] ; C. Duyckaerts [France] ; F. Javoy-Agid [France] ; J. Hauw [France] ; Yves Agid [France]Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?
005090 Jesse M. Cedarbaum [États-Unis] ; K. R. Sheu [États-Unis] ; Bradford J. Harding [États-Unis] ; John P. Blass [États-Unis] ; France Javoy-Agid [France] ; Yves Agid [France]Deficiency of glutamate dehydrogenase in postmortem brain samples from parkinsonian putamen
005091 F. Javoy-Agid [France] ; E. C. Hirsch [France] ; S. Dumas [France] ; C. Duyckaerts [France] ; J. Mallet [France] ; Yves Agid [France]Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in parkinson's disease: An in situ hybridization study
005095 J.-P Dubois [France] ; Bernard Pillon [France] ; Françlois Lhermitte [France] ; Yves Agid [France]Cholinergic deficiency and frontal dysfunction in Parkinson's disease
005096 M. Ruberg [France] ; W. Mayo [France] ; A. Brice [France] ; C. Duyckaerts [France] ; J. J Hauw [France] ; H. Simon [France] ; M. Lemoal [France] ; Yves Agid [France]Choline acetyltransferase activity and [ 3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions
005133 S. Dumas ; F. Javoy-Agid ; E. Hirsch ; Yves Agid [France] ; J. MalletTyrosine hydroxylase gene expression in human ventral mesencephalon : detection of tyrosine hydroxylase messenger RNA in neurites
005138 D. T. Dexter [Royaume-Uni] ; A. Carayon ; M. Vidailhet ; M. Ruberg ; F. Agid ; Yves Agid [France] ; A. J. Lees ; F. R. Wells ; P. Jenner ; C. D. MarsdenDecreased ferritin levels in brain in Parkinson's disease
005139 B. Dubois ; B. Pillon ; F. Lhermitte ; Yves Agid [France]Cholinergic deficiency and frontal dysfunction in Parkinson's disease
005140 S. Malessa ; E. C. Hirsch ; P. Cervera ; C. Duyckaerts ; Yves Agid [France]Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes : a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration
005142 B. Dubois ; B. Pillon ; N. Sternic ; F. Lhermitte ; Yves Agid [France]Age-induced cognitive disturbances in Parkinson's disease
005150 E C Hirsch [France] ; A M Graybiel ; L B Hersh ; C. Duyckaerts ; Yves Agid [France]Striosomes and extrastriosomal matrix contain different amounts of immunoreactive choline acetyltransferase in the human striatum.
005155 Yves Agid [France] ; P. Cervera ; E. Hirsch ; F. Javoy-Agid ; S. Lehericy ; R. Raisman ; M. RubergBiochemistry of Parkinson's disease 28 years later: a critical review.
005191 Jean Scherman [France] ; Claire Desnos [France] ; François Darchen [France] ; Pierre Pollak [France] ; France Javoy-Agid [France] ; Yves Agid [France]Striatal dopamine deficiency in parkinson's disease: Role of aging
005193 E. C. Hirsch [France] ; A. M. Graybiel [États-Unis] ; Yves Agid [France]Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease
005198 H. Taquet [France] ; F. Javoy-Agid [France] ; A. Mauborgne [France] ; J. J. Benohel [France] ; Yves Agid [France] ; F. Cesselin [France] ; M. Hamon [France]Neuropeptides in the basal ganglia of patients with Parkinson's or Steele‐Richardson's disease
005207 B. Pillon [France] ; B. Dubois [France] ; G. Cusimano [France] ; A M Bonnet [France] ; F. Lhermitte [France] ; Yves Agid [France]Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?
005208 F. Javoy-Agid [France] ; B. Scatton [France] ; M. Ruberg [France] ; R. L'Heureux [France] ; P. Cervera [France] ; R. Raisman [France] ; J.-M. Maloteaux [Belgique] ; H. Beck [France] ; Yves Agid [France]Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex
005210 A. Juncos [États-Unis, France] ; Thomas M. Engber [États-Unis] ; Rita Raisman [France] ; Zvi Susel [États-Unis] ; Florence Thibaur [France] ; Alain Ploska [France] ; Yves Agid [France] ; Thomas N. Chase [États-Unis]Continuous and intermittent levodopa differentially affect basal ganglia function
005246 D. Scherman ; C. Desnos ; F. Darchen ; P. Pollak ; F. Javoy-Agid ; Yves Agid [France]Striatal dopamine deficiency in Parkinson's disease: role of aging
005247 E. C. Hirsch ; A. M. Graybiel ; Yves Agid [France]Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease
005249 B. Pillon ; B. Dubois ; A.-M. Bonnet ; M. Esteguy ; J. Guimaraes ; J.-M. Vigouret ; F. Lhermitte ; Yves Agid [France]Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test
005254 Jean-Marie Maloteaux [Belgique] ; Marie-Agnes Vanisberg [Belgique] ; Christian Laterre [Belgique] ; France Javoy-Agid [France] ; Yves Agid [France] ; Pierre M. Laduron [France][3H]GBR 12935 binding to dopamine uptake sites: subcellular localizatio and reduction in Parkinson's disease and progressive supranuclear palsy
005256 J. Epelbaum [France] ; F. Javoy-Agid [France] ; A. Enjalbert [France] ; S. Krantic [France] ; C. Kordon [France] ; Yves Agid [France]Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy
005263 H. Taquet [France] ; M. Nomoto [Royaume-Uni] ; S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; F. Javoy-Agid [Royaume-Uni] ; A. Mauborgne [France] ; J. J. Benoliel [France] ; C. D. Marsden [Royaume-Uni] ; J. C. Legrand [France] ; Yves Agid [France] ; M. Hamon [France] ; F. Cesselin [France]Levels of MET-enkephalin, LEU-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment
005272 Laurent Pierot [France] ; Claire Desnos [France] ; Jerome Blin [France] ; Rita Raisman [France] ; Daniel Scherman [France] ; France Javoy-Agid [France] ; Merle Ruberg [France] ; Yves Agid [France]D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy
005311 Glenn M. Maloteaux [Belgique] ; E. C. Laterre [Belgique] ; P. M. Laduron [France] ; F. Javoy-Agid [France] ; Yves Agid [France]Decrease of serotonin‐S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy
005315 Jean-Marie Maloteaux [Belgique] ; Mesu' A. K. Luabeya [Belgique] ; Marie-Agnés Vanisberg [Belgique] ; E. Christian Laterre [Belgique] ; Pierre-Marie Laduron [France] ; France Javoy-Agid [France] ; Yves Agid [France]Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsy
005336 B. Dubois ; B. Pillon ; F. Legault ; Yves Agid [France] ; F. LhermitteSlowing of cognitive processing in progressive supranuclear palsy: a comparison with Parkinson's disease
005337 S. Jegou ; F. Javoy-Agid ; C. Delbende ; D. Tranchand-Bunel ; D. H. Coy ; Yves Agid [France] ; H. VaudryRegional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects
005341 J. Blin ; A.-M. Bonnet ; Yves Agid [France]Does levodopa aggravate Parkinson's disease ?
005342 E. Hirsch ; M. Ruberg ; M.-M. Portier ; M. Dardenne ; Yves Agid [France]Characterization of two antigens in parkinsonian Lewy bodies
005373 P. Delay-Goyet [France] ; J.-M. Zajac [France] ; F. Javoy-Agid [France] ; Yves Agid [France] ; B. P. Roques [France]Regional distribution of μ, δ and κ opioid receptors in human brains from controls and parkinsonian subjects
005393 Jacques Dubois [France] ; François Danzé [France] ; Bernard Pillon [France] ; Guliana Cusimano [France] ; François Lhermitte [France] ; Yves Agid [France]Cholinergic‐dependent cognitive deficits in Parkinson's disease
005394 A. M. Bonnet [France] ; A. M. Tell [France] ; P. J. Schechter [France] ; J. Grove [France] ; M. H. Saint-Hilaire [France] ; Y. De Smet [France] ; Yves Agid [France]Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea
005415 P. Dealy-Goyet ; J.-M. Zajac ; F. Javoy-Agid ; Yves Agid [France] ; B. P. RoquesRegional distribution of μ, σ and k opioid receptors in human brains from controls and parkinsonian subjects
005419 R. Cash ; R. Raisman ; A. Ploska ; Yves Agid [France]Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease
005421 A.-M. Bonnet ; Y. Loria ; M.-H. Saint-Hilaire ; F. Lhermitte ; Yves Agid [France]Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?
005422 B. Dubois ; F. Danze ; B. Pillon ; G. Cusimano ; F. Lhermitte ; Yves Agid [France]Cholinergic-dependent cognitive deficits in Parkinson's disease
005423 J. Epelbaum ; F. Javoy-Agid ; E. Hirsch ; J. J. Hauw ; C. Kordon ; S. Krantic ; Yves Agid [France]Brain somatostatin concentrations do not decrease in progressive supranuclear palsy
005424 M. Ruberg ; A. Villageois ; A.-M. Bonnet ; B. Pillon ; F. Rieger ; Yves Agid [France]Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems
005465 Roland Cash [France] ; Rita Raisman [France] ; Laurence Lanfumey [France] ; Alain Ploska [France] ; Yves Agid [France]Cellular localization of adrenergic receptors in rat and human brain
005469 Merle Ruberg [France] ; François Rieger [France] ; Albert Villageois [France] ; Anne Marie Bonnet [France] ; Yves Agid [France]Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease
005474 B. Dubois ; Yves Agid [France]Les agonistes dopaminergiques dans la maladie de Parkinson
005478 Yves Agid [France] ; H. Taquet ; F. Cesselin ; J. Epelbaum ; F. Javoy-AgidNeuropeptides and parkinson's disease
005480 B. Pillon ; B. Dubois ; F. Lhermitte ; Yves Agid [France]Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease
005482 B. Dubois ; B. Pillon ; H. De Saxce ; F. Lhermitte ; Yves Agid [France]Disappearance of Parkinsonian signs after spontaneous vascular ``thalamotomy''
005487 R. D'Antona [France] ; J. C. Baron [France] ; Y. Samson ; M. Serdaru [France] ; F. Viader [France] ; Yves Agid [France] ; J. Cambier [France]SUBCORTICAL DEMENTIA
005492 Yves Agid [France] ; F. Javoy-Agid [France]Peptides and Parkinson's disease
005498 Roland Cash [France] ; Rita Raisman [France] ; Alain Ploska [France] ; Yves Agid [France]High and low affinity [3H]imipramine binding sites in control and Parkinsonian brains
005503 Rita Raisman [France] ; Roland Cash [France] ; Merle Ruberg [France] ; France Javoy-Agid [France] ; Yves Agid [France]Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects
005505 Roland Cash [France] ; François Lasbennes [France] ; Richard Sercombe [France] ; Jacques Seylaz [France] ; Yves Agid [France]Adrenergic receptors on cerebral microvessels in control and Parkinsonian subjects
005506 Roland Cash [France] ; Rita Raisman [France] ; Merle Ruberg [France] ; Yves Agid [France]Adrenergic receptors in frontal cortex in human brain
005513 Etienne Hirsch [France] ; Merle Ruberg [France] ; Mireille Dardenne [France] ; Marie-Madeleine Portier [France] ; France Javoy-Agid [France] ; Jean-Francois Bach [France] ; Yves Agid [France]monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease
005520 B. Dubois [France] ; W. Mayo [France] ; Yves Agid [France] ; M. Le Moal [France] ; H. Simon [France]Profound disturbances of spontaneous and learned behaviors following lesions of the nucleus basalis magnocellularis in the rat
005521 L. Pique [France] ; S. Jegou [France] ; X. Bertagna [France] ; F. Javoy-Agid [France] ; D. Seurin [France] ; M. F. Proeschel [France] ; F. Girard [France] ; Yves Agid [France] ; H. Vaudry [France] ; J. P. Luton [France]Pro-opiomelanocortin peptides in the human hypothalamus: Comparative study between normal subjects and parkinson patients
005532 H. Taquet [France] ; F. Javoy-Agid [France] ; P. Giraud [France] ; J. C. Legrand [France] ; Yves Agid [France] ; F. Cesselin [France]Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain
005534 J. M. Allen [Royaume-Uni] ; A. J. Cross [Royaume-Uni] ; T. J. Crow [Royaume-Uni] ; F. Javoy-Agid [France] ; Yves Agid [France] ; S. R. Bloom [Royaume-Uni]Dissociation of neuropeptide Y and somatostatin in Parkinson's disease
005540 Jean-Louis Bissette [États-Unis] ; Charles B. Nemeroff [États-Unis] ; Michael W. Decker [États-Unis] ; John S. Kizer [États-Unis] ; Yves Agid [France] ; France Javoy-Agid [France]Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease
005553 J. C. Monfort ; F. Javoy-Agid ; J. J. Hauw ; B. Dubois ; Yves Agid [France]Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index
005554 Belinda Bokobza [France] ; Merle Ruberg [France] ; Bernard Scatton [France] ; France Javoy-Agid [France] ; Yves Agid [France][3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
005555 Merle Ruberg [France] ; Belinda Bokobza [France] ; France Javoy-Agid [France] ; Jean-Claude Montfort [France] ; Yves Agid [France][3H]spiperone binding in the nigrostriatal system in human brain
005556 Howardi Hurtig [États-Unis] ; C. Miller Fisher [États-Unis] ; E. Ringwald [Suisse] ; M. Ruberg [France] ; F. Javoy-Agid [France] ; Yves Agid [France]WHAT CAUSES PARKINSON'S DISEASE?
005596 Yves Agid [France] ; M. Ruberg [France]Cortical and subcortical dementia
005602 Roland Cash [France] ; Merle Ruberg [France] ; Rita Raisman [France] ; Yves Agid [France]Adrenergic receptors in Parkinson's disease
005607 B. Bokobza ; M. Ruberg ; B. Scatton ; F. Javoy-Agid ; Yves Agid [France][3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
005608 J.-Y. Mear ; G. Barroche ; Y. De Smet ; M. Weber ; F. Lhermitte ; Yves Agid [France]Pergolide in the treatment of Parkinson's disease
005609 D. Rougemont ; J. C. Baron ; P. Collard ; P. Bustany ; D. Comar ; Yves Agid [France]Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease
005610 C. Llorens-Cortes ; F. Javoy-Agid ; Yves Agid [France] ; H. Taquet ; J. C. SchwartzEnkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects
005611 F. Javoy-Agid ; D. Grouselle ; A. Tixier-Vidal ; Yves Agid [France]Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease
005625 M. Garbarg [France] ; F. Javoy-Agid [France] ; J. C. Schwartz [France] ; Yves Agid [France]BRAIN HISTIDINE DECARBOXYLASE ACTIVITY IN PARKINSON'S DISEASE
005626 R. Jouvent [France] ; P. Abensour [France] ; A. M. Bonnet [France] ; D. Widlocher [France] ; Yves Agid [France] ; F. Lhermitte [France]Antiparkinsonian and antidepressant effects of high doses of bromocriptine
005639 Jacques Epelbaum [France] ; Merle Ruberg [France] ; Emmanuel Moyse [France] ; France Javoy-Agid [France] ; Bruno Dubois [France] ; Yves Agid [France]Somatostatin and dementia in Parkinson's disease
005642 Bernard Scatton [France] ; France Javoy-Agid [France] ; Liliane Rouquier [France] ; Bruno Dubois [France] ; Yves Agid [France]Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease
005645 H. Taquet [France] ; F. Javoy-Agid [France] ; M. Hamon [France] ; J. C. Legrand [France] ; Yves Agid [France] ; F. Cesselin [France]Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain
005652 A. Mauborgne [France] ; F. Javoy-Agid [France] ; J. C. Legrand [France] ; Yves Agid [France] ; F. Cesselin [France]Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains
005655 Bruno Dunois [France] ; Merle Ruberg [France] ; France Javoy-Agid [France] ; Alain Ploska [France] ; Yves Agid [France]A subcortico-cortical cholinergic system is affected in Parkinson's disease
005678 H. Taquet [France] ; F. Javoy-Agid [France] ; F. Cesselin [France] ; M. Hamon [France] ; J. C. Legrand [France] ; Yves Agid [France]Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains
005689 J. M. Studler [France] ; F. Javoy-Agid [France] ; F. Cesselin [France] ; J. C. Legrand [France] ; Yves Agid [France]CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients
005784 M. Arluison [France] ; Yves Agid [France] ; F. Javoy [France]Dopaminergic nerve endings in the neostriatum of the rat—1. Identification by intracerebral injections of 5-hydroxydopamine
005791 Yves Agid [France]A propos des méthodes neurochimiques
005838 Yves Agid [France] ; France Javoy ; Jacques GlowinskiHyperactivity of Remaining Dopaminergic Neurones after Partial Destruction of the Nigro-striatal Dopaminergic System in the Rat
005949 S. Jégou [France] ; F. Javoy-Agid ; C. Delbende ; D. Tranchand-Bunel ; D H Coy ; Yves Agid ; H. VaudryRegional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects.
005969 P. Anglade [France] ; S. Tsuji ; Yves Agid ; E C HirschNeuronal plasticity and Parkinson disease.
005970 V. Mesnage [France] ; J L Houeto ; A M Bonnet ; I. Clavier ; I. Arnulf ; F. Cattelin ; G. Le Fur ; P. Damier ; M L Welter ; Yves AgidNeurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease.
005997 Yves Agid [France]Continuous high frequency stimulation of deep brain structures in brain pathology.
005999 D. Dormont [France] ; P. Cornu ; B. Pidoux ; A M Bonnet ; A. Biondi ; C. Oppenheim ; D. Hasboun ; P. Damier ; E. Cuchet ; J. Philippon ; Yves Agid ; C. MarsaultChronic thalamic stimulation with three-dimensional MR stereotactic guidance.
005A00 P. Ibá Ez [France] ; A-M Bonnet ; B. Débarges ; E. Lohmann ; F. Tison ; P. Pollak ; Yves Agid ; A. Dürr ; A. BriceCausal relation between alpha-synuclein gene duplication and familial Parkinson's disease.

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024